Citations

Citations to this article as recorded by  

• The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn
  Xuanyi Meng, Garett Dunsmore, Petya Koleva, Yesmine Elloumi, Richard You Wu, Reed Taylor Sutton, Lindsy Ambrosio, Naomi Hotte, Vivian Nguyen, Karen L Madsen, Levinus A Dieleman, Hongbing Chen, Vivian Huang, Shokrollah Elahi
  Journal of Crohn's and Colitis.2019; 13(4): 431.     CrossRef
• Factors associated with pregnancy-related knowledge in women of reproductive age with inflammatory bowel disease
  Ko Eun Lee, Sung-Ae Jung, Hyuk Yoon, Sang Hyoung Park, Chang Mo Moon, Eun Soo Kim, Seong-Eun Kim, Suk-Kyun Yang
  Scandinavian Journal of Gastroenterology.2017; 52(8): 833.     CrossRef

Citations

Citations to this article as recorded by  

• Thiamine, gastrointestinal beriberi and acetylcholine signaling
  Elliot Overton, Alina Emelyanova, Victoria I. Bunik
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• An organic state trace element solution for rheumatoid arthritis treatment by modulating macrophage phenotypic from M1 to M2
  Shuangqing Wang, Jishan Yin, Yanhong Liu, Mingji Jin, Qiming Wang, Jianpeng Guo, Zhonggao Gao
  Biomedicine & Pharmacotherapy.2024; 170: 116025.     CrossRef
• Vitamin K: Infection, Inflammation, and Auto-Immunity
  Yuanyuan Xie, Shifang Li, Dinan Wu, Yining Wang, Jiepeng Chen, Lili Duan, Shuzhuang Li, Yuyuan Li
  Journal of Inflammation Research.2024; Volume 17: 1147.     CrossRef
• Editorial: Dietary habits, microbiota and autoimmune diseases
  Manuela Berto Pucca, Julio Villena, Gislane Lelis Vilela de Oliveira
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• A COMBINATION REVIEW ON EFFECT OF CITRUS JUICE AND METRONIDAZOLE IN INFLAMMATORY BOWEL DISEASE
  Deeksha, Shalini Saini, Meenakshi Bhatt
  International Journal of Research -GRANTHAALAYAH.2023;[Epub]     CrossRef
• Parental inflammatory bowel disease and autism in children
  Aws Sadik, Christina Dardani, Panagiota Pagoni, Alexandra Havdahl, Evie Stergiakouli, Jakob Grove, Golam M. Khandaker, Sarah A. Sullivan, Stan Zammit, Hannah J. Jones, George Davey Smith, Christina Dalman, Håkan Karlsson, Renee M. Gardner, Dheeraj Rai
  Nature Medicine.2022; 28(7): 1406.     CrossRef
• Wernicke's encephalopathy in Crohn's disease and ulcerative colitis
  Erik Oudman, Jan W. Wijnia, Misha J. Oey, Mirjam van Dam, Albert Postma
  Nutrition.2021; 86: 111182.     CrossRef
• Update on Safety Profiles of Vitamins B1, B6, and B12: A Narrative Review
  Carlos-Alberto Calderon-Ospina, Mauricio Orlando Nava-Mesa, Ana María Paez-Hurtado
  Therapeutics and Clinical Risk Management.2020; Volume 16: 1275.     CrossRef
• Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease
  Kyoung Ho Ko, You Sun Kim, Bo Kyung Lee, Jong Hyun Choi, Yong Moon Woo, Jin Young Kim, Jeong Seop Moon
  Intestinal Research.2019; 17(1): 70.     CrossRef
• Serum trace elements profile in the pediatric inflammatory bowel disease progress evaluation
  Anna Stochel-Gaudyn, Krzysztof Fyderek, Paweł Kościelniak
  Journal of Trace Elements in Medicine and Biology.2019; 55: 121.     CrossRef
• The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD
  Maria Chiara Mentella, Franco Scaldaferri, Marco Pizzoferrato, Antonio Gasbarrini, Giacinto Abele Donato Miggiano
  Nutrients.2019; 11(11): 2583.     CrossRef
• Metronidazole-induced encephalopathy in a patient with Crohn's disease
  Jihye Kim, Jaeyoung Chun, Jae Yong Park, Seung Wook Hong, Joo Young Lee, Jin Woo Kang, Seongjun Hwang, Sang-Bae Ko, Jong Pil Im, Joo Sung Kim
  Intestinal Research.2017; 15(1): 124.     CrossRef

Inflammatory bowel disease (IBD) has become more common in Asia over the past few decades. The rate of increase in prevalence of the disease varies greatly in Asia, with several countries in East Asia experiencing a more than doubled increase in IBD prevalence over the past decade. Historically, ulcerative colitis (UC) is more common than Crohn's disease (CD) in Asia. However, a reverse trend is beginning to appear in more developed countries in Asia such as Japan, Korea, and Hong Kong. While Asian IBD patients share many similarities with their Western counterparts, there are important differences with significant clinical implications. In Asia, there are more men with CD, more ileo-colonic involvement in CD, less familial aggregation, fewer extra-intestinal manifestations and worse clinical outcomes for older-onset patients with UC. These differences are likely related to the different genetic makeup and environmental exposures in different regions. Evaluation of the differences and rates in epidemiologic trends may help researchers and clinicians estimate disease burden and understand the reasons behind these differences, which may hold the key to unravel the etiology of IBD.

Citations

Citations to this article as recorded by  

• Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan
  Tadakazu Hisamatsu, Makoto Naganuma, Philippe Pinton, Mitsuhiro Takeno
  Journal of Gastroenterology.2025; 60(3): 294.     CrossRef
• Management of Anal Fistula with Crohn's Disease
  Shota Takano, Yasushi Nakamura, Kohei Tamaoka, Takafumi Yoshimoto, Yasue Irei, Yoriyuki Tsuji
  Journal of the Anus, Rectum and Colon.2025; 9(1): 10.     CrossRef
• Key Themes in the Care of Inflammatory Bowel Diseases Among Immigrant Populations: A Systematic Review
  Michael Youssef, Parul Tandon, Tyrel Jones, Varun Srikanth, Laura Targownik
  Digestive Diseases and Sciences.2025;[Epub]     CrossRef
• The Importance of Post-Inflammatory Polyps (PIPs) in Colorectal Cancer Surveillance in Inflammatory Bowel Diseases
  Ivanna Candel, Panu Wetwittayakhlang, Talat Bessissow, Peter L. Lakatos
  Journal of Clinical Medicine.2025; 14(2): 333.     CrossRef
• Recent advances in epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years
  Jian Wan, Jiaming Zhou, Zhuo Wang, Dan Liu, Hao Zhang, Shengmao Xie, Kaichun Wu
  Chinese Medical Journal.2025;[Epub]     CrossRef
• Evaluation of the mechanism of action of Aegle marmelos in a murine model of 3% dextran sulphate sodium induced acute colitis
  Alok Nachane, Sandhya K. Kamat, Manoj Radhakrishnan, Gita Nataraj, Sunil S. Kuyare
  International Journal of Basic & Clinical Pharmacology.2025; 14(2): 275.     CrossRef
• Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies
  Dian-yu Zheng, Yi-nuo Wang, Yu-Hong Huang, Min Jiang, Cong Dai
  International Immunopharmacology.2024; 126: 111229.     CrossRef
• Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review
  Sudheer K Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanzel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath
  Journal of Crohn's and Colitis.2024; 18(6): 836.     CrossRef
• Efficacy and safety of moxibustion for ulcerative colitis: protocol for a systematic review and meta-analysis
  Yanzhen Li, Wen Zhou, Wenxiao Chen, Bailing Deng, Jianyu You
  BMJ Open.2024; 14(3): e078878.     CrossRef
• Trends in the prevalence and incidence of Crohn’s disease in Japan and the United States
  Ko Nakajo, Michiyo Yamazaki, Hsingwen Chung, Youran Xu, Hong Qiu
  International Journal of Colorectal Disease.2024;[Epub]     CrossRef
• Rising Incidence of Inflammatory Bowel Disease in the Asian Subcontinent—An Exploration of Causative Factors
  Priyansh Bhayani, Kartik Natarajan, Nayantara Coelho-Prabhu
  Gastrointestinal Disorders.2024; 6(2): 549.     CrossRef
• Safety and Effectiveness of Ustekinumab for Crohn’s Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan
  Katsumasa Nagano, Hiroaki Tsuchiya, Teita Asano, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
  Crohn's & Colitis 360.2024;[Epub]     CrossRef
• Osteopontin regulation of MerTK+ macrophages promotes Crohn’s disease intestinal fibrosis
  Juanhan Liu, Wenbin Gong, Peizhao Liu, Yangguang Li, Haiyang Jiang, Cunxia Wu, Xiuwen Wu, Yun Zhao, Jianan Ren
  iScience.2024; 27(7): 110226.     CrossRef
• A Continuous Registry of Medical Record, Patient Input, and Epidemiological Data of Patients With Ulcerative Colitis: a Multicentre, Prospective, Observational Clinical Registry Study in Japan
  Katsuyoshi Matsuoka, Shuji Hibiya, Katsuyoshi Ando, Yuji Tani, Takehiro Torisu, Haruei Ogino, Takanori Yamashita, Akira Andoh, Yoshihisa Sugimoto, Takayuki Matsumoto, Yusuke Iwanaga, Takashi Suda, Taku Kobayashi
  Annals of Clinical Epidemiology.2024; 6(3): 65.     CrossRef
• Temporal Trends of Inflammatory Bowel Diseases in Taiwan from 2016 to 2020: A Population-Based Study
  Chia-Jung Kuo, Cheng-Yu Lin, Puo-Hsien Le, Yao-Wei Kuo, Chen-Ming Hsu, Ming-Wei Lai, Wey-Ran Lin, Ming-Ling Chang, Ming-Yao Su, Cheng-Tang Chiu, Chee-Jen Chang
  Digestive Diseases and Sciences.2024; 69(9): 3172.     CrossRef
• Differences of clinical phenotype between familial and sporadic Crohn’s disease in East China
  Siyuan Dong, Xiaoxia Xiang, Yu Zhang, Rongbei Liu, Lingna Ye, Qian Cao
  International Journal of Colorectal Disease.2024;[Epub]     CrossRef
• Predicting novel biomarkers for early diagnosis and dynamic severity monitoring of human ulcerative colitis
  Yu Chen, Li Chen, Sheng Huang, Li Yang, Li Wang, Feiyun Yang, Jinxiu Huang, Xiuliang Ding
  Frontiers in Genetics.2024;[Epub]     CrossRef
• Concordance of phenotypic characteristics among patients with familial Crohn's disease in China
  Xiao Xia Deng, Min Zhi Lin, Xiang Gao, Xin Yu Liu, Yan Hui Wu, Kang Chao, Jian Tang
  Journal of Digestive Diseases.2024; 25(7): 444.     CrossRef
• Effects of a Pre-Conception Care Program in Women with Inflammatory Bowel Disease: A Mixed-Methods Study Including a Randomized Controlled Trial
  Young Jin Lee, Hae Won Kim, Yeon Hee Kim, Suk-Kyun Yang, Ji-Yeon Kim
  Journal of Korean Academy of Nursing.2024; 54(3): 386.     CrossRef
• Ulcerative colitis: molecular insights and intervention therapy
  Yuqing Liang, Yang Li, Chehao Lee, Ziwei Yu, Chongli Chen, Chao Liang
  Molecular Biomedicine.2024;[Epub]     CrossRef
• Perianal fistulizing lesions of Crohn’s disease are associated with long-term behavior and its transition: a Chinese cohort study
  Wei Zhan, Xiaoyin Bai, Hong Yang, Jiaming Qian
  Intestinal Research.2024; 22(4): 484.     CrossRef
• The Effects of Mannyeon-hwan on Acetic Acid-induced Ulcerative Colitis in Rats
  Won-ho Kong, Bum-hoi Kim, Won-ill Kim
  The Journal of Internal Korean Medicine.2024; 45(4): 681.     CrossRef
• Unlocking the Power of Physical Activity in Inflammatory Bowel Disease: A Comprehensive Review
  Jiajia Chen, Shaopeng Sun, Andrew S. Day
  Gastroenterology Research and Practice.2024;[Epub]     CrossRef
• Treatment Response and Safety of Herbal Medicine Combined with a Low-Carbohydrate Diet for Weight Reduction in Patients with Inflammatory Bowel Disease: A Retrospective Multicenter Study
  Ji-young Son, Su-yong Shin, Jung-sang Kim, Min-whee Kang, Dong-hun Lee, Seong-hyeon Jeon, Jun-ho Kim, Chung-hee Kim, Byung-soo Kang, Min-woo Bang
  The Journal of Internal Korean Medicine.2024; 45(6): 1136.     CrossRef
• Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
  Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, Shinichiro Shinzaki, Noritaka Takatsu, Toshimitsu Fujii, Ryuichi Okamoto, Katsuyoshi Matsuoka, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Hisashi Shiga, Shigeki Bamba, Yohei Mikami, Takahiro Shimoya
  Journal of Crohn's and Colitis.2023; 17(8): 1193.     CrossRef
• Alleviative mechanism and effect of Bifidobacterium animalisA6 on dextran sodium sulfate‐induced ulcerative colitis in mice
  Fang Wu, Guna Wuri, Bing Fang, Mengxuan Shi, Ming Zhang, Liang Zhao
  Food Science & Nutrition.2023; 11(2): 892.     CrossRef
• A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
  Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
  Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
• Safety and Effectiveness of Ustekinumab for Crohn’s Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed
  Katsumasa Nagano, Erina Hata, Teita Asano, Hiroaki Tsuchiya, Masayuki Takagishi, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
  Crohn's & Colitis 360.2023;[Epub]     CrossRef
• Risk factors for poor sleep quality in patients with inflammatory bowel disease in China: A multicenter study
  Suqi Zeng, Chuan Liu, Jixiang Zhang, Ping An, Zhongchun Liu, Changqing Jiang, Jie Shi, Kaichun Wu, Weiguo Dong
  Frontiers in Psychiatry.2023;[Epub]     CrossRef
• Comparison of the Persistence of Anti-TNF Agents and Ustekinumab in Patients with Crohn’s Disease: A Study Based on the Korean National Database
  Gi Hyeon Seo, Sung Hoon Jung
  Journal of Clinical Medicine.2023; 12(6): 2397.     CrossRef
• A review article of inflammatory bowel disease treatment and pharmacogenomics
  Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim, Amira B. Kassem
  Beni-Suef University Journal of Basic and Applied Sciences.2023;[Epub]     CrossRef
• Longitudinal trends in direct costs and healthcare utilization ascribable to inflammatory bowel disease in the biologic era: a nationwide, population‐based study
  Eun Young Park, Dong Hoon Baek, Gwang Ha Kim, Choongrak Kim, Hasung Kim, Jeong Woo Lee, Geun Am Song
  Journal of Gastroenterology and Hepatology.2023; 38(9): 1485.     CrossRef
• Mucosal immune systems of pediatric inflammatory bowel disease: A review
  Takahiro Kudo, Toshiaki Shimizu
  Pediatrics International.2023;[Epub]     CrossRef
• Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea
  Jin Woo Kim, Hyun Joo Song, Sun-Jin Boo, Heung Up Kim, Ki Soo Kang, Soo-Young Na
  The Korean Journal of Gastroenterology.2023; 81(6): 243.     CrossRef
• A web-based survey on self-management for patients with inflammatory bowel disease in Japan
  Masakazu Nagahori, Takahito Imai, Mikiko Nakashoji, Ai Tairaka, Jovelle L. Fernandez, Pei-Yuan Su
  PLOS ONE.2023; 18(7): e0287618.     CrossRef
• Vagus Nerve Stimulation Through Electro-acupuncture for Inflammatory Bowel Disease
  Minjeong Kim, Dongwon Kim, Chaehyun Park, Jae-Woo Park, Seok-Jae Ko
  The Journal of Internal Korean Medicine.2023; 44(3): 455.     CrossRef
• Diagnosis of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Han Hee Lee, Jae Jun Park, Bo-In Lee, Ida Hilmi, Jose Sollano, Zhi Hua Ran
  Intestinal Research.2023; 21(3): 328.     CrossRef
• Magnolia officinalis bark extract improves depressive-like behavior in DSS-induced colitis mice
  Min-Soo Kim, Jungim Kim, Kang-In Lee, Hye Jin Kim, Hyungjun Kim, Donghwan Kim, Ki-Sun Park
  Journal of Functional Foods.2023; 108: 105775.     CrossRef
• Treatment Patterns in Newly Diagnosed Patients with Crohn’s Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan
  Fumihito Hirai, Akihito Uda, Mihoko Ota, Yukiko Takemura, Keisuke Tanaka, Ryuichi Iwakiri
  Digestion.2023; 104(2): 109.     CrossRef
• IBD barriers across the continents – East Asia
  Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Lycium barbarum polysaccharide alleviates DSS-induced chronic ulcerative colitis by restoring intestinal barrier function and modulating gut microbiota
  Zhi-Yu Li, Lan-Hui Lin, He-Jun Liang, Ya-Qi Li, Fu-Qian Zhao, Ting-Yi Sun, Zi-Yu Liu, Jing-Yi Zhu, Feng Gu, Jia-Ning Xu, Qi-Yuan Hao, De-Shan Zhou, Hui-Hong Zhai
  Annals of Medicine.2023;[Epub]     CrossRef
• Geographical heterogeneity in the disease characteristics and management of patients with inflammatory bowel disease, the preliminary results of a Chinese database for IBD (CHASE-IBD)
  Jian Wan, Jun Shen, Xiaoping Wu, Jie Zhong, Yan Chen, Lanxiang Zhu, Yinglei Miao, Naizhong Hu, Jie Chen, Jie Liang, Kaichun Wu
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Vaccination strategies for Korean patients with inflammatory bowel disease
  Yoo Jin Lee, Eun Soo Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
• Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index—A Report from the ImageKids Study
  Sapir Choshen, Dan Turner, Li-Tal Pratt, Ronit Precel, Mary-Louise Greer, Denise A Castro, Amit Assa, María I Martínez-León, Izabela Herman-Sucharska, Eva Coppenrath, Osnat Konen, Jorge Davila, Elhamy Bekhit, Zehour Alsabban, Gili Focht, Matan Gavish, Ann
  Inflammatory Bowel Diseases.2022; 28(5): 700.     CrossRef
• Beneficial effect of capsaicin via TRPV4/EDH signals on mesenteric arterioles of normal and colitis mice
  Luyun Zhang, Wei Lu, Cheng Lu, Yanjun Guo, Xiongying Chen, Jun Chen, Feng Xu, Hanxing Wan, Hui Dong
  Journal of Advanced Research.2022; 39: 291.     CrossRef
• The Involvement of Glial Cell-Derived Neurotrophic Factor in Inflammatory Bowel Disease
  HuiLing Chen, TiYun Han, LiPing Gao, DeKui Zhang
  Journal of Interferon & Cytokine Research.2022; 42(1): 1.     CrossRef
• Active and passive smoking and risk of ulcerative colitis: A case–control study in Japan
  Atsushi Nishikawa, Keiko Tanaka, Yoshihiro Miyake, Chisato Nagata, Shinya Furukawa, Akira Andoh, Tetsuji Yokoyama, Naoki Yoshimura, Kenichiro Mori, Tomoyuki Ninomiya, Yasunori Yamamoto, Eiji Takeshita, Yoshio Ikeda, Mitsuru Saito, Katsuhisa Ohashi, Hirots
  Journal of Gastroenterology and Hepatology.2022; 37(4): 653.     CrossRef
• Combined Endoscopic and Radiologic Healing Is Associated With a Better Prognosis Than Endoscopic Healing Only in Patients With Crohn's Disease Receiving Anti-TNF Therapy
  Kyunghwan Oh, Eun Hye Oh, Soo Min Noh, Seong Ho Park, Nayoung Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
  Clinical and Translational Gastroenterology.2022; 13(1): e00442.     CrossRef
• Clinical Characteristics of Crohn's Disease in a Cohort from Saudi Arabia
  Yousef A. Qari
  Saudi Journal of Medicine & Medical Sciences.2022; 10(1): 56.     CrossRef
• Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data
  Seo-Hee Kim, Yujin Park, Seong Pyo Kim, Sung Hee Lee, Seak Hee Oh, Suk-Kyun Yang, Hyung-Jin Yoon, Kyung Mo Kim
  Digestive Diseases and Sciences.2022; 67(11): 5079.     CrossRef
• Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
  Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Olivares, Isabel Vera, Míriam Mañosa, Javier P. Gisbert, Mariam Aguas, Eugenia Sánchez-Rodríguez, Maia Bosca-Watts, Viviana Laredo, Blau Camps, Ignacio Marín-Jiménez, Y
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Screening and Evaluation of Probiotics for Reducing Intestinal Inflammation
  雅君 陈
  Hans Journal of Food and Nutrition Science.2022; 11(01): 44.     CrossRef
• Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab
  Rosanne Ottevanger, Rutger C. Melchers, Koen D. Quint
  JAAD Case Reports.2022; 22: 34.     CrossRef
• Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update
  Shanmugaprakasham Selvamani, Vijay Mehta, Hesham Ali El Enshasy, Suganthi Thevarajoo, Hala El Adawi, Ibrahim Zeini, Khoa Pham, Theodoros Varzakas, Bassam Abomoelak
  Saudi Journal of Biological Sciences.2022; 29(5): 3546.     CrossRef
• Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South‐East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease‐Emerging Nations' Consortium
  Rupa Banerjee, Partha Pal, Ida Hilmi, Uday C Ghoshal, Devendra C Desai, Mohammed Masudur Rahman, Usha Dutta, Syed A Mohiuddin, Munnera Al Mohannadi, Mathew Philip, Ganesh N Ramesh, Madunil A Niriella, Arjuna P De Silva, Hithanadura Janaka de Silva, Pises
  Journal of Gastroenterology and Hepatology.2022; 37(6): 1004.     CrossRef
• Changes in the Long-term Prognosis of Crohn’s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study
  Byong Duk Ye, Sung Noh Hong, Seung In Seo, Ye-Jee Kim, Jae Myung Cha, Kyoung Hoon Rhee, Hyuk Yoon, Young-Ho Kim, Kyung Ho Kim, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim,
  Gut and Liver.2022; 16(2): 216.     CrossRef
• Capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption by blocking TRPV4 channels in healthy and colitic mice
  Hanxing Wan, Xiong Ying Chen, Fenglian Zhang, Jun Chen, Fenglan Chu, Zachary M. Sellers, Feng Xu, Hui Dong
  Journal of Biological Chemistry.2022; 298(5): 101847.     CrossRef
• Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
  Ji Min Lee, Shu-Chen Wei, Kang-Moon Lee, Byong Duk Ye, Ren Mao, Hyun-Soo Kim, Soo Jung Park, Sang Hyoung Park, Eun Hye Oh, Jong Pil Im, Byung Ik Jang, Dae Bum Kim, Ken Takeuchi
  Gut and Liver.2022; 16(3): 396.     CrossRef
• The Effect of Empowering Education Combined With Mindfulness Meditation Training on Negative Emotion and Quality of Life in Patients With Inflammatory Bowel Disease
  Wei-Zhen Xi, Chong-Wu Xu, Ling-Ling Wang
  Frontiers in Behavioral Neuroscience.2022;[Epub]     CrossRef
• The first association study of Protein Tyrosine Phosphatase, Non-Receptor Type 2 (PTPN2) gene polymorphisms in Malaysian patients with Crohn’s disease
  Xiang Ting Goh, Suh Kuan Fong, Hwa Chia Chai, Boon Pin Kee, Kek Heng Chua
  Gene.2022; 836: 146661.     CrossRef
• The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
  Xinwei Xu, Dickson Kofi Wiredu Ocansey, Sanhua Hang, Bo Wang, Samuel Amoah, Chengxue Yi, Xu Zhang, Lianqin Liu, Fei Mao
  Gut Pathogens.2022;[Epub]     CrossRef
• Differences in MUC2 Gene Expression Based on the Clinical Severity of Colitis and the Degree of Histopathological Damage to the Colonic Mucosa in Colitis-induced Rat
  Saptino Miro, Arni Amir, Nasrul Zubir, Andani Eka Putra
  Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 1170.     CrossRef
• Trend and Geographic Variation in Incidence and Prevalence of Inflammatory Bowel Disease in Regions Across China: A Nationwide Employee Study Between 2013 and 2016
  Hong Yang, Runing Zhou, Xiaoyin Bai, Mingyue Guo, Gechong Ruan, Li Wang, Jiaming Qian
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Mechanism of electroacupuncture and herb-partitioned moxibustion on ulcerative colitis animal model: A study based on proteomics
  Qin Qi, Rui Zhong, Ya-Nan Liu, Chen Zhao, Yan Huang, Yuan Lu, Zhe Ma, Han-Dan Zheng, Lu-Yi Wu
  World Journal of Gastroenterology.2022; 28(28): 3644.     CrossRef
• Evaluating macro‐ and micronutrients and food groups intake with the risk of developing inflammatory bowel disease: Is there any association?
  Farnaz Farsi, Negin Tahvilian, Azadeh Heydarian, Sara Karimi, Sara Ebrahimi, Nasser Ebrahimi‐Daryani, Sanam Tabataba‐Vakili, Javad Heshmati, Marjan Mokhtare
  Food Science & Nutrition.2022; 10(11): 3920.     CrossRef
• Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease
  Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, Hyun Mi Lee, Won Eui Yoon, Seo Hyun Kim, Hee Jun Myung, Jeong Seop Moon
  Intestinal Research.2022; 20(3): 321.     CrossRef
• Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
  Seung Yong Shin, Soo Jung Park, Young Kim, Jong Pil Im, Hyo Jong Kim, Kang-Moon Lee, Ji Won Kim, Sung-Ae Jung, Jun Lee, Sang-Bum Kang, Sung Jae Shin, Eun Sun Kim, You Sun Kim, Tae Oh Kim, Hyun-Soo Kim, Dong Il Park, Hyung Kil Kim, Eun Soo Kim, Young-Ho Ki
  Intestinal Research.2022; 20(3): 350.     CrossRef
• Landscape of inflammatory bowel disease in Singapore
  Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi
  Intestinal Research.2022; 20(3): 291.     CrossRef
• Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
  Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Kenji Watanabe, Hisashi Shiga, Noritaka Takatsu, Shigeki Bamba, Yohei Mikami, Takayuki Yamamoto, Takahiro Shimoyama, Satoshi Motoya, Takehiro Torisu,
  Journal of Gastroenterology.2022; 57(11): 867.     CrossRef
• Neutralizing Antibody Response, Safety, and Efficacy of mRNA COVID-19 Vaccines in Pediatric Patients with Inflammatory Bowel Disease: A Prospective Multicenter Case—Control Study
  Kyung Jae Lee, So Yoon Choi, Yoo Min Lee, Han Wool Kim
  Vaccines.2022; 10(8): 1265.     CrossRef
• Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019
  Yang Zhang, Jiali Liu, Xiao Han, Hui Jiang, Liming Zhang, Juncong Hu, Lei Shi, Junxiang Li
  Frontiers in Public Health.2022;[Epub]     CrossRef
• What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?
  Su Bee Park, Jin Young Yoon, Jae Myung Cha
  Gut and Liver.2022; 16(5): 676.     CrossRef
• Pilot study of an elimination diet in adults with mild to moderate Crohn’s disease
  Neeraj Narula, Emily C.L. Wong, Paul Moayyedi, Walter Reinisch, John K. Marshall
  European Journal of Gastroenterology & Hepatology.2022; 34(12): 1210.     CrossRef
• Natural history of inflammatory bowel disease: a comparison between the East and the West
  Eun Mi Song, Suk-Kyun Yang
  Intestinal Research.2022; 20(4): 418.     CrossRef
• Treatment with Extracellular Vesicles from Giardia lamblia Alleviates Dextran Sulfate Sodium-Induced Colitis in C57BL/6 Mice
  Hyun Jung Kim, Young-Ju Lee, Seon-Ok Back, Shin-Hyeong Cho, Hee-Il Lee, Myoung-Ro Lee
  The Korean Journal of Parasitology.2022; 60(5): 309.     CrossRef
• Uptake and Advanced Therapy of Butyrate in Inflammatory Bowel Disease
  Shinji Ota, Hirotake Sakuraba
  Immuno.2022; 2(4): 692.     CrossRef
• Long-Term Trends in the Burden of Inflammatory Bowel Disease in China Over Three Decades: A Joinpoint Regression and Age-Period-Cohort Analysis Based on GBD 2019
  Yang Zhang, Jiali Liu, Xiao Han, Hui Jiang, Liming Zhang, Juncong Hu, Lei Shi, Junxiang Li
  SSRN Electronic Journal .2022;[Epub]     CrossRef
• Differences in inflammatory bowel diseases between East and West: a Chinese perspective
  Guanglin Cui, Junling Li, Hanzhe Liu, Jann-Birger Laugsand, Zhanju Liu
  Journal of Public Health.2021; 29(1): 19.     CrossRef
• Structural and functional changes in the brain of patients with Crohn’s disease: an activation likelihood estimation meta-analysis
  Andy Wai Kan Yeung
  Brain Imaging and Behavior.2021; 15(2): 807.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia
  Zhihua Ran, Kaichun Wu, Katsuyoshi Matsuoka, Yoon Tae Jeen, Shu Chen Wei, Vineet Ahuja, Minhu Chen, Pin‐Jin Hu, Akira Andoh, Hyo Jong Kim, Suk‐Kyun Yang, Mamoru Watanabe, Siew Chien Ng, Toshifumi Hibi, Ida Normiha Hilmi, Yasuo Suzuki, Dong Soo Han, Wai Ke
  Journal of Gastroenterology and Hepatology.2021; 36(3): 637.     CrossRef
• Exclusive enteral nutrition is effective and feasible as primary induction and re‐induction therapy in Asian children with Crohn's disease
  Kok Joo Chan, Zhi Liang Song, Kee Seang Chew, Ruey Terng Ng, Siti Hawa Mohd Taib, Way Seah Lee
  Journal of Paediatrics and Child Health.2021; 57(2): 239.     CrossRef
• The four epidemiological stages in the global evolution of inflammatory bowel disease
  Gilaad G. Kaplan, Joseph W. Windsor
  Nature Reviews Gastroenterology & Hepatology.2021; 18(1): 56.     CrossRef
• Zinc and Selenium in Inflammatory Bowel Disease: Trace Elements with Key Roles?
  Mostafa Vaghari-Tabari, Davoud Jafari-Gharabaghlou, Fatemeh Sadeghsoltani, Parisa Hassanpour, Durdi Qujeq, Nadereh Rashtchizadeh, Amir Ghorbanihaghjo
  Biological Trace Element Research.2021; 199(9): 3190.     CrossRef
• Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
  Shu-Chen Wei, Jose Sollano, Yee Tak Hui, Wei Yu, Paul V. Santos Estrella, Lyndon John Q. Llamado, Nana Koram
  Expert Review of Gastroenterology & Hepatology.2021; 15(3): 275.     CrossRef
• Mycosis fungoides in a patient with ulcerative colitis on anti-tumor necrosis factor-alpha therapy
  Takeshi Yasuda, Tomohisa Takagi, Jun Asai, Norito Katoh, Junya Kuroda, Yasumichi Kuwahara, Yukiko Morinaga, Eiichi Konishi, Kazuhiko Uchiyama, Yuji Naito, Yoshito Itoh
  Clinical Journal of Gastroenterology.2021; 14(1): 170.     CrossRef
• The Response of the Tongue Epithelial on Cigarette Smoke Exposure as a Risk Factor for Oral Cancer Development
  Neken Prasetyaningtyas, Nabilah Azzahra Jatiatmaja, Desiana Radithia, Hening Tuti Hendarti, Adiastuti Endah Parmadiati, Priyo Hadi, Fatma Yasmin Mahdani, Diah Savitri Ernawati, Rosnah binti Zain, Nurina Febriyanti Ayuningtyas
  European Journal of Dentistry.2021; 15(02): 320.     CrossRef
• Racial disparities exist in surgical outcomes for patients with inflammatory bowel disease
  Isabel C. Dos Santos Marques, Lauren M. Theiss, Lauren N. Wood, Drew J. Gunnells, Robert H. Hollis, Karin M. Hardiman, Jamie A. Cannon, Melanie S. Morris, Gregory D. Kennedy, Daniel I. Chu
  The American Journal of Surgery.2021; 221(4): 668.     CrossRef
• Astragalin Inhibits Nuclear Factor-κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice
  Yoo Min Han, Jaemoon Koh, Jee Hyun Kim, Jooyoung Lee, Jong Pil Im, Joo Sung Kim
  Gut and Liver.2021; 15(1): 100.     CrossRef
• Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
  Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
  Gut and Liver.2021; 15(1): 92.     CrossRef
• Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study
  Jeongseok Kim, Hyuk Yoon, Nayoung Kim, Kang-Moon Lee, Sung-Ae Jung, Chang Hwan Choi, Eun Soo Kim, Yunho Jung, Chang Soo Eun, Tae Oh Kim, Sang-Bum Kang, You Sun Kim, Geom-Seog Seo, Chang Kyun Lee, Jong Pil Im, Soo Jung Park, Dong Il Park, Byong Duk Ye
  Inflammatory Bowel Diseases.2021; 27(12): 1931.     CrossRef
• Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
  Toshifumi Hibi, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel
  Intestinal Research.2021; 19(1): 53.     CrossRef
• Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan
  Yutaro Soejima, Yohei Kirino, Mitsuhiro Takeno, Michiko Kurosawa, Masaki Takeuchi, Ryusuke Yoshimi, Yumiko Sugiyama, Shigeru Ohno, Yukiko Asami, Akiko Sekiguchi, Toshihisa Igarashi, Shohei Nagaoka, Yoshiaki Ishigatsubo, Hideaki Nakajima, Nobuhisa Mizuki
  Arthritis Research & Therapy.2021;[Epub]     CrossRef
• Differential effects of EPA and DHA on DSS-induced colitis in mice and possible mechanisms involved
  Zhuangwei Zhang, Zhe Xue, Haitao Yang, Feng Zhao, Chundi Liu, Jiahui Chen, Songtao Lu, Zuquan Zou, Yuping Zhou, Xiaohong Zhang
  Food & Function.2021; 12(4): 1803.     CrossRef
• Proteinuria Is Associated with the Development of Crohn’s Disease: A Nationwide Population-Based Study
  Seona Park, Hyun Jung Lee, Kyung-Do Han, Hosim Soh, Jung Min Moon, Seung Wook Hong, Eun Ae Kang, Jong Pil Im, Joo Sung Kim
  Journal of Clinical Medicine.2021; 10(4): 799.     CrossRef
• Maternal Emulsifier P80 Intake Induces Gut Dysbiosis in Offspring and Increases Their Susceptibility to Colitis in Adulthood
  Ge Jin, Qiang Tang, Jiaheng Ma, Xiang Liu, Bingqian Zhou, Yue Sun, Xiaoqi Pang, Zixuan Guo, Runxiang Xie, Tianyu Liu, Bangmao Wang, Hailong Cao, Hongwei Zhou
  mSystems.2021;[Epub]     CrossRef
• Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats
  Ping Wang, Yan Chen, La-Mei Zhang, Si-Qi Yuan, Shen-Ao Lu, Ying-Jian Zhang
  Life Sciences.2021; 278: 119603.     CrossRef
• Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study
  Neeraj Narula, Emily C L Wong, Mahshid Dehghan, Andrew Mente, Sumathy Rangarajan, Fernando Lanas, Patricio Lopez-Jaramillo, Priyanka Rohatgi, P V M Lakshmi, Ravi Prasad Varma, Andres Orlandini, Alvaro Avezum, Andreas Wielgosz, Paul Poirier, Majid A Almadi
  BMJ.2021; : n1554.     CrossRef
• Evaluation of economic burden with biologic treatments in Crohn’s disease patients: A mirror image study using an insurance database in Japan
  Celine Miyazaki, Nagano Katsumasa, Kuan Chih Huang, Yan Fang Liu, Kevin Lu
  PLOS ONE.2021; 16(7): e0254807.     CrossRef
• Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post‐marketing surveillance in Japan
  Seiji Yokoyama, Teita Asano, Katsumasa Nagano, Hiroaki Tsuchiya, Masayuki Takagishi, Shigeharu Tsujioka, Naomi Miura, Takayuki Matsumoto
  Journal of Gastroenterology and Hepatology.2021; 36(11): 3069.     CrossRef
• Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
  Shin Ju Oh, Ga Young Shin, Hosim Soh, Jae Gon Lee, Jong Pil Im, Chang Soo Eun, Kang-Moon Lee, Dong Il Park, Dong Soo Han, Hyo Jong Kim, Chang Kyun Lee
  Intestinal Research.2021; 19(3): 323.     CrossRef
• Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
  Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park
  Medicine.2021; 100(34): e27065.     CrossRef
• Epidemiology and diagnosis of inflammatory bowel diseases
  Kang-Moon Lee
  Journal of the Korean Medical Association.2021; 64(9): 579.     CrossRef
• MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2
  Siwen Tang, Wentao Guo, Liumin Kang, Jinghua Liang
  Journal of Molecular Histology.2021; 52(6): 1215.     CrossRef
• Incident Crohn’s Disease as a Risk Factor for Colorectal Cancer in the First 10 Years after Diagnosis: A Nationwide Population-Based Study
  Hyunil Kim, Ji Hoon Kim, Jung Kuk Lee, Dae Ryong Kang, Su Young Kim, Hyun-Soo Kim, Hee Man Kim
  Journal of Clinical Medicine.2021; 10(20): 4663.     CrossRef
• Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department
  Asaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, Bella Ungar, Shelly Soffer, Marianne M. Amitai, Eyal Klang, Uri Kopylov
  Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
• Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
  Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi
  Intestinal Research.2021; 19(4): 408.     CrossRef
• Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease
  Guanglin Cui, Hanzhe Liu, Gang Xu, Jann-Birger Laugsand, Zhigang Pang
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
  Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano
  Intestinal Research.2021; 19(4): 386.     CrossRef
• Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
  Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi
  Intestinal Research.2021; 19(4): 419.     CrossRef
• Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study
  Ju-Young Shin, Hye-Min Park, Min-Young Lee, Ja-Young Jeon, Hyun-Jeong Yoo, Byong Duk Ye
  Gut and Liver.2021; 15(6): 867.     CrossRef
• Clinical Remission of Crohn’s Disease Induced by Herbal Decoction (Jinmoo-tang): A Case Report
  Byunghee Lee, Jiyoon Won, Hyangsook Lee
  Journal of Physiology & Pathology in Korean Medicine.2021; 35(6): 255.     CrossRef
• Incidence and risk factors of Pneumocystis jirovecii pneumonia in Korean patients with inflammatory bowel disease
  Kwangwoo Nam, Sang Hyoung Park, Junghwan Lee, Seokjung Jo, Seon‐Ok Kim, Soomin Noh, Jae Cheol Park, Jin Yong Kim, Jeongseok Kim, Nam Seok Ham, Eun Hye Oh, Eun Mi Song, Sung Wook Hwang, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Ky
  Journal of Gastroenterology and Hepatology.2020; 35(2): 218.     CrossRef
• Potential influential factors on incidence and prevalence of inflammatory bowel disease in mainland China
  Yuqi Qiao, Zhihua Ran
  JGH Open.2020; 4(1): 11.     CrossRef
• Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
  Luis Hernandez, Hiroyo Kuwabara, Anshul Shah, Kaoru Yamabe, Heather Burnett, Kyle Fahrbach, Maria Koufopoulou, Ryuichi Iwakiri
  PharmacoEconomics.2020; 38(1): 69.     CrossRef
• Nutritional and dietary strategy in the clinical care of inflammatory bowel disease
  Meng-Shu Hsieh, Wen-Hung Hsu, Jiunn-Wei Wang, Yao-Kuang Wang, Huang-Ming Hu, Wei-Kuo Chang, Chih-Yen Chen, Deng-Chyang Wu, Fu-Chen Kuo, Wei-Wen Su
  Journal of the Formosan Medical Association.2020; 119(12): 1742.     CrossRef
• UK Patients of Bangladeshi Descent with Crohn’s Disease Respond Less Well to TNF Antagonists Than Caucasian Patients
  Radha Gadhok, Hannah Gordon, Gregory Sebepos-Rogers, Samantha Baillie, Saniath Akbar, Jane E. Abbott, Emma Michael, Omer F. Ahmad, Ben Cooper, James O. Lindsay
  Digestive Diseases and Sciences.2020; 65(6): 1790.     CrossRef
• Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
• Intestinal Epithelial Deletion of Sphk1 Prevents Colitis-Associated Cancer Development by Inhibition of Epithelial STAT3 Activation
  Seung Bin Park, Byung-il Choi, Beom Jae Lee, Nam Joo Kim, Yoon A. Jeong, Moon Kyung Joo, Hyo Jung Kim, Jong-Jae Park, Jae Seon Kim, Yoon-Seok Noh, Hyun Joo Lee
  Digestive Diseases and Sciences.2020; 65(8): 2284.     CrossRef
• High-fat diet-derived free fatty acids impair the intestinal immune system and increase sensitivity to intestinal epithelial damage
  Shohei Tanaka, Yasuhiro Nemoto, Yuria Takei, Ryo Morikawa, Shigeru Oshima, Takashi Nagaishi, Ryuichi Okamoto, Kiichiro Tsuchiya, Tetsuya Nakamura, Susanne Stutte, Mamoru Watanabe
  Biochemical and Biophysical Research Communications.2020; 522(4): 971.     CrossRef
• Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses
  Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi
  Journal of Gastroenterology.2020; 55(3): 291.     CrossRef
• Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn’s disease treated with antitumor necrosis factor-alpha agents based on Parks’ classification
  Nahla Azzam, Othman Alharbi, Majid Almadi, Abdulrahman Aljebreen, Turki AlAmeel, Mohammed Alabbas, Salman Bahammam, Ahmed Bashmail, Yasser Alomar, Mahmoud Mosli
  European Journal of Gastroenterology & Hepatology.2020; 32(2): 187.     CrossRef
• Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Yonsei Medical Journal.2020; 61(1): 48.     CrossRef
• Nicotine-induced autophagy via AMPK/mTOR pathway exerts protective effect in colitis mouse model
  Qian Gao, Pinduan Bi, Ding Luo, Ying Guan, Wanli Zeng, Haiying Xiang, Qili Mi, Guangyu Yang, Xuemei Li, Bin Yang
  Chemico-Biological Interactions.2020; 317: 108943.     CrossRef
• Emerging Involvement of long non-coding RNAs in gastrointestinal associated inflammatory disorders
  Hamed Esmaeil Lashgarian, Maryam Karkhane, Abdolrazagh Marzban, Mohammad Yazdi, Kiana Shahzamani
  Comparative Immunology, Microbiology and Infectious Diseases.2020; 69: 101428.     CrossRef
• Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Jooyoung Lee, Jong Pil Im, Kyungdo Han, Jihye Kim, Hyun Jung Lee, Jaeyoung Chun, Joo Sung Kim
  Gut and Liver.2020; 14(1): 89.     CrossRef
• Trends in Healthcare Costs for Inflammatory Bowel Disease in South Korea
  Yoon Suk Jung
  Gut and Liver.2020; 14(1): 3.     CrossRef
• Role of microRNA-449a in the progress of inflammatory bowel disease in children
  Dandan Zhao, Na Wu, Libo Wang, Xiaoli Pang, Xuehua Liu, Xiaohong Zhang
  Biotechnology & Biotechnological Equipment.2020; 34(1): 144.     CrossRef
• Lovastatin derivative dehydrolovastatin ameliorates ulcerative colitis in mice by suppressing NF-κB and inflammatory cytokine expression
  Xu Zhang, Qing-Hua Deng, Jian-Hua Deng, Sheng-Ju Wang, Qiu Chen
  The Korean Journal of Physiology & Pharmacology.2020; 24(2): 137.     CrossRef
• Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling
  Akihito Uda, Yuki Eto, Yuxin Li, Hiroyuki Matsuda, Sven Demiya, Tomoyuki Watanabe, Mihoko Ota, Ryuichi Iwakiri, Ataru Igarashi
  Crohn's & Colitis 360.2020;[Epub]     CrossRef
• Effect of Berberine from Coptis chinensis on Apoptosis of Intestinal Epithelial Cells in a Mouse Model of Ulcerative Colitis: Role of Endoplasmic Reticulum Stress
  Shen Yan, Liu Yingchao, Wang Zhangliu, Ruan Xianli, Li Si, Ni Siyi, Zhong Jihong, Sokcheon Pak
  Evidence-Based Complementary and Alternative Medicine.2020;[Epub]     CrossRef
• Ethanol extract of Pycnoporus sanguineus relieves the dextran sulfate sodium-induced experimental colitis by suppressing helper T cell-mediated inflammation via apoptosis induction
  Xiaohong Chen, Muxia Li, Dan Li, Ting Luo, Yizhen Xie, Liang Gao, Yifan Zhang, Shaodan Chen, Shunxian Li, Guoxin Huang, Wenzhi Li, Jiyan Su, Xiaoping Lai
  Biomedicine & Pharmacotherapy.2020; 127: 110212.     CrossRef
• Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review
  Ming Han Cha, Miguel Regueiro, Dalbir S Sandhu
  World Journal of Gastroenterology.2020; 26(19): 2323.     CrossRef
• Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI: A cohort study
  Xiaolong Ge, Huaying Liu, Shasha Tang, Yan Wu, Yipeng Pan, Wei Liu, Weilin Qi, Lingna Ye, Qian Cao, Wei Zhou
  International Journal of Surgery.2020; 79: 294.     CrossRef
• Patterns of Ulcerative Colitis Treatments and Factors Affecting the Prescribing of Systemic Corticosteroid using Health Insurance Claims Database
  Jiyool Kim, So-Hee Park, Ju-Young Shin
  Korean Journal of Clinical Pharmacy.2020; 30(2): 102.     CrossRef
• Polysaccharide isolated from Auricularia auricular‐judae (Bull.) prevents dextran sulfate sodium‐induced colitis in mice through modulating the composition of the gut microbiota
  Di Zhao, Wenjing Dai, Heng Tao, Wei Zhuang, Mi Qu, Ya‐Ning Chang
  Journal of Food Science.2020; 85(9): 2943.     CrossRef
• Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country
  Mortada HF El-Shabrawi, Sara Tarek, Maha Abou-Zekri, Safa Meshaal, Afaf Enayet, Engy Adel Mogahed
  World Journal of Gastrointestinal Pharmacology and Therapeutics.2020; 11(3): 48.     CrossRef
• Is the rise in Crohn’s disease in India accompanied by a fall in intestinal tuberculosis? A single-center experience
  Pavan Dhoble, Devendra Desai, Philip Abraham
  Indian Journal of Tuberculosis.2020;[Epub]     CrossRef
• Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India
  Pabitra Sahu, Sudheer K. Vuyyuru, Bhaskar Kante, Ashish Agarwal, Raju Sharma, Prasenjit Das, Rajesh Panwar, Saransh Jain, Sawan Bopanna, Govind Makharia, Saurabh Kedia, Vineet Ahuja
  Indian Journal of Gastroenterology.2020; 39(4): 388.     CrossRef
• The effect of miRNA and autophagy on colorectal cancer
  Jiali Long, Qinglian He, Yuting Yin, Xue Lei, Ziqi Li, Wei Zhu
  Cell Proliferation.2020;[Epub]     CrossRef
• Periodontitis combined with smoking increases risk of the ulcerative colitis: A national cohort study
  Eun Ae Kang, Jaeyoung Chun, Jee Hyun Kim, Kyungdo Han, Hosim Soh, Seona Park, Seung Wook Hong, Jung Min Moon, Jooyoung Lee, Hyun Jung Lee, Jun-Beom Park, Jong Pil Im, Joo Sung Kim
  World Journal of Gastroenterology.2020; 26(37): 5661.     CrossRef
• An assessment of dietary intake, food avoidance and food beliefs in patients with ulcerative colitis of different disease status
  Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, Raja Affendi Raja Ali
  Intestinal Research.2020; 18(4): 447.     CrossRef
• Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
  Kenji Watanabe
  Intestinal Research.2020; 18(4): 347.     CrossRef
• Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study
  Hussein Mahajna, Yiftach Barash, Bella Ungar, Shelly Soffer, Ahmad Albshesh, Asaf Levartovsky, Shomron Ben-Horin, Eyal Klang, Uri Kopylov
  Journal of Clinical Medicine.2020; 9(11): 3651.     CrossRef
• Preconception Care Program for Women with Inflammatory Bowel Disease Using Intervention Mapping: A Protocol for Program Development
  Young Jin Lee, Yeon Hee Kim, Hae Won Kim
  International Journal of Environmental Research and Public Health.2020; 17(24): 9365.     CrossRef
• Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice
  Seong-Joon Koh, Youn-I Choi, Yuri Kim, Yoo-Sun Kim, Sang Woon Choi, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee
  European Journal of Nutrition.2019; 58(4): 1603.     CrossRef
• Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
  Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
  Intestinal Research.2019; 17(1): 54.     CrossRef
• 5‐Hydroxytryptamine (5‐HT)‐exacerbated DSS‐induced colitis is associated with elevated NADPH oxidase expression in the colon
  Shizhen Dong, Menglu Chen, Faliang Dai, Qingxia Xuan, Pan Chen, Dandan Feng, Lei Gao, Chendi Zhu, Yongchao Chang, Fong‐Fong Chu, Qiang Gao
  Journal of Cellular Biochemistry.2019; 120(6): 9230.     CrossRef
• Emerging trends of inflammatory bowel disease in South Korea: A nationwide population‐based study
  Min Seob Kwak, Jae Myung Cha, Hun Hee Lee, Yong Sung Choi, Seung In Seo, Kyung Jin Ko, Dong Il Park, Sung Hun Kim, Tae Jun Kim
  Journal of Gastroenterology and Hepatology.2019; 34(6): 1018.     CrossRef
• Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease
  Kyoung Ho Ko, You Sun Kim, Bo Kyung Lee, Jong Hyun Choi, Yong Moon Woo, Jin Young Kim, Jeong Seop Moon
  Intestinal Research.2019; 17(1): 70.     CrossRef
• Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study
  Seung Kim, Sowon Park, Yunkoo Kang, Jung Eun Kim, Ben Kang, Byung‐Ho Choe, Yeoun Joo Lee, Jae Hong Park, Hye Ran Yang, Sung Hee Lee, Kyung Mo Kim, Eell Ryoo, Hann Tchah, Jung Ok Shim, Hong Koh
  Journal of Pediatric Gastroenterology and Nutrition.2019; 68(1): 45.     CrossRef
• Detection and management of early stage inflammatory bowel disease: an update for clinicians
  Laura Loy, Giulia Roda, Gionata Fiorino, Mariangela Allocca, Federica Furfaro, Marjorie Argollo, Laurent Peyrin-Biroulet, Silvio Danese
  Expert Review of Gastroenterology & Hepatology.2019; 13(6): 547.     CrossRef
• Anti-inflammatory effects of mulberry twig extracts on dextran sulfate sodium-induced colitis mouse model
  Xuelei Cui, Eunjung Kim
  Journal of Nutrition and Health.2019; 52(2): 139.     CrossRef
• A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986–2015
  Sang Hyoung Park, Ye-Jee Kim, Kyoung Hoon Rhee, Young-Ho Kim, Sung Noh Hong, Kyung Ho Kim, Seung In Seo, Jae Myung Cha, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan K
  Journal of Crohn's and Colitis.2019; 13(11): 1410.     CrossRef
• Dose–response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study
  Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
  Journal of Gastroenterology.2019; 54(10): 881.     CrossRef
• A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease
  Eun Jin Jang, Jung Eun Ha, Seul Gi Im, Myeong Gyu Kim, Hyun Soon Sohn
  Clinical Drug Investigation.2019; 39(7): 625.     CrossRef
• Exposure of the Host-Associated Microbiome to Nutrient-Rich Conditions May Lead to Dysbiosis and Disease Development—an Evolutionary Perspective
  Tim Lachnit, Thomas C. G. Bosch, Peter Deines, Margaret J. McFall-Ngai
  mBio.2019;[Epub]     CrossRef
• Inflammatory bowel disease incidence, prevalence and 12‐month initial disease course in Tasmania, Australia
  Rajesh Bhatia, Sern Wei Yeoh, Karl Vaz, Corrie Studd, Jarrad Wilson, Sally Bell, Petr Otahal, Alison Venn
  Internal Medicine Journal.2019; 49(5): 622.     CrossRef
• Crohn’s Disease: Potential Drugs for Modulation of Autophagy
  Nursyuhada Azzman
  Medicina.2019; 55(6): 224.     CrossRef
• Systematic review with meta‐analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease
  Adam Tepler, Neeraj Narula, Richard M. Peek, Anish Patel, Cyrus Edelson, Jean‐Frederic Colombel, Shailja C. Shah
  Alimentary Pharmacology & Therapeutics.2019; 50(2): 121.     CrossRef
• A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia
  Norfilza Mohd Mokhtar, Khairul Najmi Muhammad Nawawi, Jaarvis Verasingam, Wong Zhiqin, Ismail Sagap, Zairul Azwan Mohd Azman, Luqman Mazlan, Hamzaini Abdul Hamid, Nur Yazmin Yaacob, Isa Mohamed Rose, Eden Low Ngah Den, Mah Suit Wan, Raja Affendi Raja Ali
  BMC Public Health.2019;[Epub]     CrossRef
• Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
  You-Jung Choi, Eue-Keun Choi, Kyung-Do Han, Jiesuck Park, Inki Moon, Euijae Lee, Won-Seok Choe, So-Ryoung Lee, Myung-Jin Cha, Woo-Hyun Lim, Seil Oh
  World Journal of Gastroenterology.2019; 25(22): 2788.     CrossRef
• Emotional dysfunction and inflammatory bowel disease
  Si-Hui Li, Qiao-Feng Wu
  World Chinese Journal of Digestology.2019; 27(12): 727.     CrossRef
• Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014)
  Jung Eun Ha, Eun Jin Jang, Seul Gi Im, Hyun Soon Sohn
  Korean Journal of Clinical Pharmacy.2019; 29(2): 79.     CrossRef
• Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis
  Nava Morshedzadeh, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Vahid Chaleshi, Azita Hekmatdoost, Soheila Karimi, Mohammad Reza Zali, Parvin Mirmiran
  Complementary Therapies in Medicine.2019; 46: 36.     CrossRef
• Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study
  Yoon Jin Choi, Dong Ho Lee, Dong Woo Shin, Kyung‐Do Han, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim
  Alimentary Pharmacology & Therapeutics.2019; 50(7): 769.     CrossRef
• Taraxacum officinale extract ameliorates dextran sodium sulphate‐induced colitis by regulating fatty acid degradation and microbial dysbiosis
  Wei Chen, Huining Fan, Rui Liang, Rui Zhang, Jing Zhang, Jinshui Zhu
  Journal of Cellular and Molecular Medicine.2019; 23(12): 8161.     CrossRef
• Marked regional variations in the prevalence of inflammatory bowel disease in a limited geographical region are not associated with compounds in the drinking water
  Fredrik Segerman, Spencer Clarkson, Klas Sjöberg
  Scandinavian Journal of Gastroenterology.2019; 54(10): 1250.     CrossRef
• Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome
  Simon Ghaly, Prue H. Hart, Ian C Lawrance
  Expert Review of Gastroenterology & Hepatology.2019; 13(11): 1039.     CrossRef
• Prognosis of synchronous colorectal carcinoma compared to solitary colorectal carcinoma: a matched pair analysis
  Wanbin He, Chengjun Zheng, Yonghong Wang, Jie Dan, Mingjie Zhu, Mingtian Wei, Jian Wang, Ziqiang Wang
  European Journal of Gastroenterology & Hepatology.2019; 31(12): 1489.     CrossRef
• Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
  Jooyoung Lee, Jong Pil Im, Kyungdo Han, Seona Park, Hosim Soh, Kukhwan Choi, Jihye Kim, Jaeyoung Chun, Joo Sung Kim
  World Journal of Gastroenterology.2019; 25(42): 6354.     CrossRef
• Huang-Lian-Jie-Du Decoction Ameliorates Acute Ulcerative Colitis in Mice via Regulating NF-κB and Nrf2 Signaling Pathways and Enhancing Intestinal Barrier Function
  Ziwen Yuan, Lihong Yang, Xiaosong Zhang, Peng Ji, Yongli Hua, Yanming Wei
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients
  Qin Cao, Yu-Hong Huang, Min Jiang, Cong Dai
  Scandinavian Journal of Gastroenterology.2019; 54(12): 1458.     CrossRef
• Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study
  Wei-Chen Lin, Meng-Tzu Weng, Chien-Chih Tung, Yuan-Ting Chang, Yew-Loong Leong, Yu-Ting Wang, Horng-Yuan Wang, Jau-Min Wong, Shu-Chen Wei
  Journal of Translational Medicine.2019;[Epub]     CrossRef
• Knowledge and Viewpoints on Biosimilar Monoclonal Antibodies among Asian Physicians: Comparison with European Physicians
  Soo-Kyung Park, Won Moon, Eun Soo Kim, Sang Hyun Park, Dong Il Park
  The Korean Journal of Gastroenterology.2019; 74(6): 333.     CrossRef
• BIOSAFETY OF THE FAR EAST REGION OF RUSSIA: EPIDEMIOLOGICAL AND EPIZOOTIC TRENDS
  Natalya A. Kuznetsova, B. G Andryukov
  Epidemiology and Infectious Diseases.2019; 24(3): 128.     CrossRef
• Colonoscopic abnormalities in patients with IBD in a referral hospital in Salvador - Bahia
  Carlos Ramon Silveira Mendes, Taísa Maria Brito Amorim, Lana Ferreira Moreira, Rafaela Mendonça Leal, Adriana Conceição de Mello Andrade
  Gastroenterology & Hepatology: Open Access.2019;[Epub]     CrossRef
• Switching off Inflammation with Diet: A Review of Exclusive Enteral Nutrition in Children with Crohn’s Disease
  Andrew S. Day
  EMJ Gastroenterology.2019; : 86.     CrossRef
• The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease
  Shiyuan Wang, Yan Huang, Cili Zhou, Huangan Wu, Jimeng Zhao, Luyi Wu, Min Zhao, Fang Zhang, Huirong Liu
  Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
• Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis
  Sedigheh Pouya, Maryam Heidari, Kaveh Baghaei, Hamid Asadzadeh Aghdaei, Afshin Moradi, Saeed Namaki, Mohammad Reza Zali, Seyed Mahmoud Hashemi
  International Immunopharmacology.2018; 54: 86.     CrossRef
• Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study
  Suk Jin Hong, Seung Man Cho, Byung-Ho Choe, Hyo Jeong Jang, Kwang Hae Choi, Ben Kang, Jung Eun Kim, Jun Hyun Hwang
  Journal of Korean Medical Science.2018;[Epub]     CrossRef
• A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease
  Guanglin Cui, Aping Yuan
  Frontiers in Medicine.2018;[Epub]     CrossRef
• Herb-partitioned moxibustion alleviates colon injuries in ulcerative colitis rats
  Dan Zhang, Yan-Bo Ren, Kai Wei, Jue Hong, Yan-Ting Yang, Li-Jie Wu, Ji Zhang, Zheng Shi, Huan-Gan Wu, Xiao-Peng Ma
  World Journal of Gastroenterology.2018; 24(30): 3384.     CrossRef
• How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
  You Sun Kim
  The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef
• Disease Activity Patterns Recorded Using a Mobile Monitoring System Are Associated with Clinical Outcomes of Patients with Crohn’s Disease
  Eun Soo Kim, Sung Kook Kim, Byung Ik Jang, Kyeong Ok Kim, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Sang Gyu Kwak
  Digestive Diseases and Sciences.2018; 63(9): 2220.     CrossRef
• Efficacy of herb-partitioned moxibustion at Qihai (CV 6) and bilateral Tianshu (ST 25) on colonic damage and the TLR4/NF-κB signaling pathway in rats with Crohn's disease
  Zhang Dan, Wei Kai, Ma Xiaopeng, Wu Huangan, Hong Jue, Zhang Cuihong, Wu Lingxiang, Yan Huang, Liu Jie, Zhu Yi, Yang Ling
  Journal of Traditional Chinese Medicine.2018; 38(2): 218.     CrossRef
• Novel treatments for inflammatory bowel disease
  Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
  The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
• Rapid rise in the incidence and clinical characteristics of pediatric inflammatory bowel disease in a South–East Asian cohort in Singapore, 1994–2015
  Christina Ong, Marion M Aw, Maria J Liwanag, Seng H Quak, Kong B Phua
  Journal of Digestive Diseases.2018; 19(7): 395.     CrossRef
• Urbanization and the gut microbiota in health and inflammatory bowel disease
  Tao Zuo, Michael A. Kamm, Jean-Frédéric Colombel, Siew C. Ng
  Nature Reviews Gastroenterology & Hepatology.2018; 15(7): 440.     CrossRef
• Molecular diagnosis and classification of inflammatory bowel disease
  Hu Zhang, Zhen Zeng, Arjudeb Mukherjee, Bo Shen
  Expert Review of Molecular Diagnostics.2018; 18(10): 867.     CrossRef
• Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis
  Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee
  Intestinal Research.2018; 16(2): 216.     CrossRef
• Predictors and clinical outcomes of follow‐up loss in patients with inflammatory bowel disease
  Dae Hyung Woo, Kyeong Ok Kim, Min Kyu Kang, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
  Journal of Gastroenterology and Hepatology.2018; 33(11): 1834.     CrossRef
• Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study
  Saransh Jain, Saurabh Kedia, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Peush Sahni, Sujoy Pal, Nihar Ranjan Dash, Govind Makharia, Simon P. L. Travis, Vineet Ahuja
  Intestinal Research.2018; 16(1): 69.     CrossRef
• Risk factors for inflammatory bowel disease: A prospective multi-center study
  Anjali D. Amarapurkar, Deepak N. Amarapurkar, Pravin Rathi, Prabha Sawant, Nikhil Patel, Praful Kamani, Krishnakant Rawal, Rajiv Baijal, Ameya Sonawane, Nitin Narawane, Samrat Kolekar, Naveen Totla
  Indian Journal of Gastroenterology.2018; 37(3): 189.     CrossRef
• Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
  Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi
  Intestinal Research.2018; 16(2): 233.     CrossRef
• Genomic characterization of colitis-associated colorectal cancer
  Hitoshi Kameyama, Masayuki Nagahashi, Yoshifumi Shimada, Yosuke Tajima, Hiroshi Ichikawa, Masato Nakano, Jun Sakata, Takashi Kobayashi, Sumana Narayanan, Kazuaki Takabe, Toshifumi Wakai
  World Journal of Surgical Oncology.2018;[Epub]     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• Significant Medical and Surgical Morbidity in Perianal Crohn’s Disease: Results from a Territory-Wide Study
  Wing Yan Mak, Oi Sze Mak, Choon Kin Lee, Whitney Tang, Wai Keung Leung, Marc T L Wong, Alex Shun Fung Sze, Michael Li, Chi Man Leung, Fu Hang Lo, Belsy C Y Lam, Kam Hon Chan, Edwin Hok Shing Shan, Steven Woon Choy Tsang, Aric J Hui, Wai Hung Chow, Francis
  Journal of Crohn's and Colitis.2018;[Epub]     CrossRef
• Neat1-miRNA204-5p-PI3K-AKT axis as a potential mechanism for photodynamic therapy treated colitis in mice
  Kunpeng Wang, Zijian Zhang, Kai Liu, Xin Yang, Heng Zou, Jiangjiao Zhou, Xiongying Miao, Wei Chen, Li Xiong, Yu Wen
  Photodiagnosis and Photodynamic Therapy.2018; 24: 349.     CrossRef
• Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
  Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim
  World Journal of Gastroenterology.2018; 24(42): 4798.     CrossRef
• Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies
  Garima Juyal, Ajit Sood, Vandana Midha, B. K. Thelma
  Journal of Genetics.2018; 97(5): 1493.     CrossRef
• Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
  Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2018; 12(5): 544.     CrossRef
• Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease
  Christina Ong, Poh Ting Lim, Veena Logarajah, Maria Janelle Liwanag, Bi Xia Ang, Yuqin Cher, Fang Kuan Chiou, Ajmal Kader
  BMC Gastroenterology.2018;[Epub]     CrossRef
• Incidence and clinical outcomes of intestinal Behçet’s disease in Korea, 2011–2014: a nationwide population-based study
  Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park
  Journal of Gastroenterology.2017; 52(8): 920.     CrossRef
• Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: A retrospective study
  Dong Juan Song, Jin Lu Tong, Jiang Chen Peng, Chen Wen Cai, Xi Tao Xu, Ming Ming Zhu, Zhi Hua Ran, Qing Zheng
  Journal of Digestive Diseases.2017; 18(1): 23.     CrossRef
• Role of MiRNAs in Inflammatory Bowel Disease
  Bo Cao, Xin Zhou, Jiaojiao Ma, Wei Zhou, Wanli Yang, Daiming Fan, Liu Hong
  Digestive Diseases and Sciences.2017; 62(6): 1426.     CrossRef
• Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases
  Jean-Frederic Colombel, Neeraj Narula, Laurent Peyrin-Biroulet
  Gastroenterology.2017; 152(2): 351.     CrossRef
• Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
  Jong Pil Im
  Intestinal Research.2017; 15(2): 147.     CrossRef
• Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
  Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chi
  Intestinal Research.2017; 15(3): 285.     CrossRef
• Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
  Chang Soo Eun
  Intestinal Research.2017; 15(2): 145.     CrossRef
• Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease
  Jee Hyun Kim, Ji Won Kim
  Korean Journal of Gastroenterology.2017; 70(4): 162.     CrossRef
• Second Korean guidelines for the management of Crohn's disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  Intestinal Research.2017; 15(1): 38.     CrossRef
• Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia
  Eun Soo Kim
  Intestinal Research.2017; 15(1): 5.     CrossRef
• Tofacitinib for Ulcerative Colitis — A Promising Step Forward
  Sonia Friedman
  New England Journal of Medicine.2017; 376(18): 1792.     CrossRef
• Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
  Toshifumi Hibi, Yuya Imai, Yoko Murata, Nobuko Matsushima, Richuan Zheng, Christopher Gasink
  Intestinal Research.2017; 15(4): 475.     CrossRef
• Clinical course of ulcerative colitis patients who develop acute pancreatitis
  Jong Wook Kim, Sung Wook Hwang, Sang Hyoung Park, Tae Jun Song, Myung-Hwan Kim, Ho-Su Lee, Byong Duk Ye, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
  World Journal of Gastroenterology.2017; 23(19): 3505.     CrossRef
• Second Korean Guidelines for the Management of Crohn's Disease
  Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee
  The Korean Journal of Gastroenterology.2017; 69(1): 29.     CrossRef
• Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
  Eun Hye Oh, Dae-Hyun Ko, Hyungil Seo, Kiju Chang, Gwang-Un Kim, Eun Mi Song, Myeongsook Seo, Ho-Su Lee, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
  World Journal of Gastroenterology.2017; 23(8): 1489.     CrossRef
• An update on diagnostic and prognostic biomarkers in inflammatory bowel disease
  Andrew S. Day, Steven T. Leach, Daniel A. Lemberg
  Expert Review of Molecular Diagnostics.2017; 17(9): 835.     CrossRef
• Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
  Suraj Kumar, Sawan Bopanna, Saurabh Kedia, Pratap Mouli, Rajan Dhingra, Rajesh Padhan, Mikashmi Kohli, Jigyasa Chaubey, Rohini Sharma, Prasenjit Das, S Dattagupta, Govind Makharia, SK Sharma, Vineet Ahuja
  Intestinal Research.2017; 15(2): 187.     CrossRef
• Second Korean Guideline for the Management of Ulcerative Colitis
  Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
  The Korean Journal of Gastroenterology.2017; 69(1): 1.     CrossRef
• Factors associated with pregnancy-related knowledge in women of reproductive age with inflammatory bowel disease
  Ko Eun Lee, Sung-Ae Jung, Hyuk Yoon, Sang Hyoung Park, Chang Mo Moon, Eun Soo Kim, Seong-Eun Kim, Suk-Kyun Yang
  Scandinavian Journal of Gastroenterology.2017; 52(8): 833.     CrossRef
• Malignant Melanoma of the Anus Found during Routine Colonoscopy in Ulcerative Colitis
  Kwang Il Seo, Won Moon, Sung Eun Kim, Moo In Park, Seun Ja Park
  The Korean Journal of Gastroenterology.2017; 69(6): 368.     CrossRef
• Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner
  Changhyun Lee, Byeong Gwan Kim, Jee Hyun Kim, Jaeyoung Chun, Jong Pil Im, Joo Sung Kim
  International Immunopharmacology.2017; 51: 47.     CrossRef
• Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study
  Yoon Suk Jung, Minkyung Han, Won Ho Kim, Sohee Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2017; 62(8): 2102.     CrossRef
• Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study
  Yoon Suk Jung, Minkyung Han, Sohee Park, Won Ho Kim, Jae Hee Cheon
  Journal of Crohn's and Colitis.2017; 11(8): 954.     CrossRef
• Second Korean guidelines for the management of ulcerative colitis
  Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
  Intestinal Research.2017; 15(1): 7.     CrossRef
• Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn’s disease with poor prognostic factors
  Eun Hye Oh, Kyunghwan Oh, Minkyu Han, Hyungil Seo, Kiju Chang, Sun-Ho Lee, Gwang-Un Kim, Eun Mi Song, Myeongsook Seo, Ho-Su Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
  PLOS ONE.2017; 12(5): e0177479.     CrossRef
• Development of a Novel Predictive Model for the Clinical Course of Crohnʼs Disease
  Yehyun Park, Jae Hee Cheon, Yi Lang Park, Byong Duk Ye, You Sun Kim, Dong Soo Han, Joo Sung Kim, Sung Noh Hong, Young Ho Kim, Seong Ran Jeon, Won Ho Kim
  Inflammatory Bowel Diseases.2017; 23(7): 1071.     CrossRef
• RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohnʼs Disease Patients Compared with Normal Mucosa of Healthy Controls
  Sung Noh Hong, Je-Gun Joung, Joon Seol Bae, Chan Soo Lee, Ja Seol Koo, Soo Jung Park, Jong Pil Im, You Sun Kim, Ji Won Kim, Woong Yang Park, Young-Ho Kim
  Inflammatory Bowel Diseases.2017; 23(7): 1098.     CrossRef
• The Phase 3 Trials of Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
  Sang Hyoung Park
  The Korean Journal of Gastroenterology.2017; 69(1): 90.     CrossRef
• Role of Smoking as a Risk Factor in East Asian Patients with Crohn's Disease
  Sung Chul Park, Yoon Tae Jeen
  Gut and Liver.2017; 11(1): 7.     CrossRef
• Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life
  Jin Young Yoon, Jeong Eun Shin, Sang Hyoung Park, Dong Il Park, Jae Myung Cha
  Gut and Liver.2017; 11(3): 370.     CrossRef
• Practice patterns and clinical significance of use of capsule endoscopy in suspected and established Crohn's disease
  Yonghyun Kim, Seong Ran Jeon, Sang Myung Choi, Hyun Gun Kim, Tae Hee Lee, Jun-Hyung Cho, Yunho Jung, Wan Jung Kim, Bong Min Ko, Jin-Oh Kim, Joon Sung Lee, Moon Sung Lee
  Intestinal Research.2017; 15(4): 467.     CrossRef
• Epidemiology, Natural History, and Risk Stratification of Crohn's Disease
  Satimai Aniwan, Sang Hyoung Park, Edward V. Loftus
  Gastroenterology Clinics of North America.2017; 46(3): 463.     CrossRef
• Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis
  Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Seong Woo Jeon, Hyun Jin Kim, Sung Kook Kim
  Digestive Diseases and Sciences.2017; 62(9): 2489.     CrossRef
• Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease
  Jung Won Lee
  Gut and Liver.2017; 11(4): 449.     CrossRef
• Pivot to Asia: inflammatory bowel disease burden
  Prashant Singh, Ashwin Ananthakrishnan, Vineet Ahuja
  Intestinal Research.2017; 15(1): 138.     CrossRef
• Temporal Trend of Pediatric Inflammatory Bowel Disease
  Takashi Ishige, Takeshi Tomomasa, Reiko Hatori, Maiko Tatsuki, Yoshiko Igarashi, Kazuhiko Sekine, Hirokazu Arakawa
  Journal of Pediatric Gastroenterology and Nutrition.2017;[Epub]     CrossRef
• Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease
  Hyun Ho Choi, Young-Seok Cho
  Gut and Liver.2017; 11(3): 319.     CrossRef
• X Chromosome-wide Association Study Identifies a Susceptibility Locus for Inflammatory Bowel Disease in Koreans
  Ho-Su Lee, Hyunjung Oh, Suk-Kyun Yang, Jiwon Baek, Seulgi Jung, Myunghee Hong, Kyung Mo Kim, Hyoung Doo Shin, Kyung-Jo Kim, Sang Hyoung Park, Byong Duk Ye, Buhm Han, Kyuyoung Song
  Journal of Crohn's and Colitis.2017; 11(7): 820.     CrossRef
• Asians Have More Perianal Crohn Disease and Ocular Manifestations Compared with White Americans
  Bharati Kochar, Edward L. Barnes, Hans H. Herfarth, Christopher F. Martin, Ashwin N. Ananthakrishnan, Dermot McGovern, Millie D. Long, Robert S. Sandler
  Inflammatory Intestinal Diseases.2017; 2(3): 147.     CrossRef
• NF-kappa B activation correlates with disease phenotype in Crohn’s disease
  Yoo Min Han, Jaemoon Koh, Ji Won Kim, Changhyun Lee, Seong-Joon Koh, ByeongGwan Kim, Kook Lae Lee, Jong Pil Im, Joo Sung Kim, Gernot Sellge
  PLOS ONE.2017; 12(7): e0182071.     CrossRef
• Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity
  Jung Hwan Oh
  Journal of Neurogastroenterology and Motility.2016; 22(4): 545.     CrossRef
• Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I
  Takuya Yoshino, Hiroshi Nakase, Tomohisa Takagi, Shigeki Bamba, Yusuke Okuyama, Takuji Kawamura, Teruki Oki, Hirozumi Obata, Chiharu Kawanami, Shinji Katsushima, Toshihiro Kusaka, Tomoyuki Tsujikawa, Yuji Naito, Akira Andoh, Takafumi Kogawa
  BMJ Open Gastroenterology.2016; 3(1): e000122.     CrossRef

For the control of Crohn's disease (CD) a thorough assessment of the small intestine is essential; several modalities may be utilized, with cross-sectional imaging being important. Magnetic resonance (MR) enterography, i.e., MRE is recommended as a modality with the highest accuracy for CD lesions. MRE and MR enteroclysis are the two methods performed following distension of the small intestine. MRE has sensitivity and specificity comparable to computed tomography enterography (CTE); although images obtained using MRE are less clear compared with CTE, MRE does not expose the patient to radiation and is superior for soft-tissue contrast. Furthermore, it can assess not only static but also dynamic and functional imaging and reveals signs of CD, such as abscess, comb sign, fat edema, fistula, lymph node enhancement, less motility, mucosal lesions, stricture, and wall enhancement. Several indices of inflammatory changes and intestinal damage have been proposed for objective evaluation. Recently, diffusion-weighted imaging has been proposed, which does not need bowel preparation and contrast enhancement. Comprehension of the characteristics of MRE and other modalities is important for better management of CD.

Citations

Citations to this article as recorded by  

• MR Enterography
  Harsha K. Garg, Kumar K. Shashi, Jessica Kurian, Abbey J. Winant, Edward Y. Lee
  Radiologic Clinics of North America.2025;[Epub]     CrossRef
• Motility Mapping Quantification Using the Classical Optical Flow Algorithm for Small Bowel Crohn’s Disease: Comparison with Balloon-assisted Enteroscopy Findings
  Yoshio Kitazume, Kento Takenaka, Kazuo Ohtsuka, Yasuo Ozawa, Koichiro Kimura, Ryosuke Watanabe, Junichi Tsuchiya, Toshimitsu Fujii, Masakazu Nagahori, Mamoru Watanabe, Ukihide Tateishi
  Magnetic Resonance in Medical Sciences.2023; 22(3): 325.     CrossRef
• Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
  Giuseppe Cicero, Silvio Mazziotti
  Intestinal Research.2021; 19(4): 365.     CrossRef
• Magnetic Resonance Enterography and Capsule Endoscopy in Patients Undergoing Patency Capsule for the Evaluation of Small Bowel Crohn’s Disease: A Korean Clinical Experience
  Hyun Seok Lee, Yun Jeong Lim, Jin-Hee Jung, Ji Hyung Nam, Junseok Park, Sun Hyung Kang, Ki Bae Kim, Hoon Jai Chun
  Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
• Efficacy of Novel Ultrathin Single-Balloon Enteroscopy for Crohn’s Disease: A Propensity Score-Matched Study
  Kaoru Takabayashi, Naoki Hosoe, Motohiko Kato, Yukie Hayashi, Ryoichi Miyanaga, Kosaku Nanki, Kayoko Fukuhara, Yohei Mikami, Shinta Mizuno, Tomohisa Sujino, Makoto Mutaguchi, Makoto Naganuma, Naohisa Yahagi, Haruhiko Ogata, Takanori Kanai
  Gut and Liver.2020; 14(5): 619.     CrossRef
• High b-value computed diffusion-weighted imaging for differentiating bowel inflammation in Crohn's disease
  Yoshio Kitazume, Junichi Tsuchiya, Kento Takenaka, Kazuo Ohtsuka, Koichiro Kimura, Ryosuke Watanabe, Tomoyuki Fujioka, Toshimitsu Fujii, Mamoru Watanabe, Ukihide Tateisi
  European Journal of Radiology.2020; 133: 109362.     CrossRef
• The role of small bowel endoscopy for Crohn's disease
  Stefania Chetcuti Zammit, Pierre Ellul, Reena Sidhu
  Current Opinion in Gastroenterology.2019; 35(3): 223.     CrossRef
• Magnetic resonance enterography predicts the prognosis of Crohn's disease
  Ji Hoon Lee, Yong Eun Park, Nieun Seo, Hyun Jung Lee, Soo Jung Park, Tae Il Kim, Won Ho Kim, Joon Seok Lim, Jae Hee Cheon
  Intestinal Research.2018; 16(3): 445.     CrossRef
• Quality Indicators for Small Bowel Capsule Endoscopy
  Ki-Nam Shim, Seong Ran Jeon, Hyun Joo Jang, Jinsu Kim, Yun Jeong Lim, Kyeong Ok Kim, Hyun Joo Song, Hyun Seok Lee, Jae Jun Park, Ji Hyun Kim, Jaeyoung Chun, Soo Jung Park, Dong-Hoon Yang, Yang Won Min, Bora Keum, Bo-In Lee
  Clinical Endoscopy.2017; 50(2): 148.     CrossRef

The gastrointestinal (GI) tract is colonized by a dense community of commensal microorganisms referred to as the gut microbiota. The gut microbiota and the host have co-evolved, and they engage in a myriad of immunogenic and metabolic interactions. The gut microbiota contributes to the maintenance of host health. However, when healthy microbial structure is perturbed, a condition termed dysbiosis, the altered gut microbiota can trigger the development of various GI diseases including inflammatory bowel disease, colon cancer, celiac disease, and irritable bowel syndrome. There is a growing body of evidence suggesting that multiple intrinsic and extrinsic factors, such as genetic variations, diet, stress, and medication, can dramatically affect the balance of the gut microbiota. Therefore, these factors regulate the development and progression of GI diseases by inducing dysbiosis. Herein, we will review the recent advances in the field, focusing on the mechanisms through which intrinsic and extrinsic factors induce dysbiosis and the role a dysbiotic microbiota plays in the pathogenesis of GI diseases.

Citations

Citations to this article as recorded by  

• Probiotics in autism spectrum disorders: a systematic review of clinical studies and future directions
  Olga Barba-Vila, Helena García-Mieres, Belén Ramos
  Nutrition Reviews.2025; 83(2): 329.     CrossRef
• Characteristics of gut microbiota profiles in Asian elephants (Elephas maximus) with gastrointestinal disorders
  Sarisa Klinhom, Chanon Kunasol, Sirawit Sriwichaiin, Sasiwan Kerdphoo, Nipon Chattipakorn, Siriporn C. Chattipakorn, Chatchote Thitaram
  Scientific Reports.2025;[Epub]     CrossRef
• The immune response modulated by inoculation of commensal bacteria at birth impacts the gut microbiota and prevents Salmonella colonization
  Florent Kempf, Rosanna Drumo, Anne Marie Chaussé, Pierrette Menanteau, Tereza Kubasova, Sylvie Roche, Anne Christine Lalmanach, Rodrigo Guabiraba, Thierry Chaumeil, Guillaume Larivière-Gauthier, Ignacio Caballero-Posadas, Béatrice Laroche, Ivan Rychlík, I
  Gut Microbes.2025;[Epub]     CrossRef
• Integrating Biological Domain Knowledge with Machine Learning for Identifying Colorectal-Cancer-Associated Microbial Enzymes in Metagenomic Data
  Burcu Bakir-Gungor, Nur Sebnem Ersoz, Malik Yousef
  Applied Sciences.2025; 15(6): 2940.     CrossRef
• Valorization of Cow Manure: Unraveling Bacterial Community Changes Driven by Vermicomposting and Their Impact on Vermicompost Tea Production
  Lorena Uribe-Lorío, Laura Brenes-Guillén, Rodolfo WingChing-Jones, Lidieth Uribe, Fernando García, César Rodríguez, Luis Felipe Aráuz
  Waste and Biomass Valorization.2024; 15(4): 2175.     CrossRef
• Metabolic network of the gut microbiota in inflammatory bowel disease
  Kohei Sugihara, Nobuhiko Kamada
  Inflammation and Regeneration.2024;[Epub]     CrossRef
• Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach
  Mahima Chowdhury, Neil Raj Chaudhary, Paranjeet Kaur, Anju Goyal, Sanjeev Kumar Sahu
  Infectious Disorders - Drug Targets.2024;[Epub]     CrossRef
• Wake up and smell the coffee: The potential of faecal volatile organic compounds in paediatric inflammatory bowel disease
  Eva Vermeer, Nanne K. H. de Boer, Tim G. J. de Meij
  United European Gastroenterology Journal.2024; 12(6): 660.     CrossRef
• Risk factors and clinical outcomes associated with multiple as opposed to single pathogens detected on the gastrointestinal disease polymerase chain reaction assay
  Insa Mannstadt, Alexa M. Choy, Jianhua Li, Daniel A. Green, Daniel E. Freedberg
  Gut Pathogens.2024;[Epub]     CrossRef
• Overcoming Biopotency Barriers: Advanced Oral Delivery Strategies for Enhancing the Efficacy of Bioactive Food Ingredients
  Ling Liu, David Julian McClements, Xuebo Liu, Fuguo Liu
  Advanced Science.2024;[Epub]     CrossRef
• Hospitalization throws the preterm gut microbiome off-key
  Jing Qian, Emily N. Yeo, Matthew R. Olm
  Cell Host & Microbe.2024; 32(10): 1651.     CrossRef
• Dietary Polyphenols, Food Processing and Gut Microbiome: Recent Findings on Bioavailability, Bioactivity, and Gut Microbiome Interplay
  Monika Sejbuk, Iwona Mirończuk-Chodakowska, Sercan Karav, Anna Maria Witkowska
  Antioxidants.2024; 13(10): 1220.     CrossRef
• Gastrointestinal pathophysiology in long COVID: Exploring roles of microbiota dysbiosis and serotonin dysregulation in post-infectious bowel symptoms
  Linda Chia-Hui Yu
  Life Sciences.2024; 358: 123153.     CrossRef
• Fecal microbiota transplantation from postmenopausal osteoporosis human donors accelerated bone mass loss in mice
  Tinglong Chen, Ning Wang, Yongqiang Hao, Lingjie Fu
  Frontiers in Cellular and Infection Microbiology.2024;[Epub]     CrossRef
• Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS
  Bahman Yousefi, Ali Babaeizad, Seyedeh Zahra Banihashemian, Zahra Khatibiyan Feyzabadi, Mehdi Dadashpour, Daryoush Pahlevan, Hadi Ghaffari, Majid Eslami
  Current Microbiology.2023;[Epub]     CrossRef
• Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities
  A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan
  Rational Pharmacotherapy in Cardiology.2023; 19(1): 58.     CrossRef
• Metabolites, gene expression, and gut microbiota profiles suggest the putative mechanisms via which dietary creatine increases the serum taurine and g-ABA contents in Megalobrama amblycephala
  Yizhuo Hua, Wangwang Huang, Fan Wang, Zhao Jing, Juntao Li, Qingchao Wang, Yuhua Zhao
  Fish Physiology and Biochemistry.2023; 49(2): 253.     CrossRef
• HIV Tat Expression and Cocaine Exposure Lead to Sex- and Age-Specific Changes of the Microbiota Composition in the Gut
  Lu Li, Xiaojie Zhao, Johnny J. He
  Microorganisms.2023; 11(3): 799.     CrossRef
• In vitro fermentation of epilactose and epilactitol by human faecal microbiota
  Yuwei Zhang, Yu Qiao, Xiaoqing Xu, Qing Peng, Jinwei Ren, Lan Ma, Dandan Tian, Yuxin Gong, Deqin Feng, Bo Shi
  International Dairy Journal.2023; 144: 105697.     CrossRef
• Growth performance, blood metabolites, ruminal fermentation, and bacterial community in preweaning dairy calves fed corn silage-included starter and total mixed ration
  Jun Zhang, Jiaqi Shang, Yangyi Hao, Yajing Wang, Zhijun Cao, Hongjian Yang, Wei Wang, Shengli Li
  Journal of Dairy Science.2023; 106(7): 4545.     CrossRef
• A short-term bioreactor assay to assess the effect of essential oils on a microbiota derived from piglet’s intestinal content
  Mathieu Bellerose, Philippe Fravalo, Isabelle Mainville, Yves Arcand, Alexandre Thibodeau
  Acta Veterinaria Scandinavica.2023;[Epub]     CrossRef
• Potential of olive oil and its phenolic compounds as therapeutic intervention against colorectal cancer: a comprehensive review
  Arindam Sain, Sakshi Sahu, Debdut Naskar
  British Journal of Nutrition.2022; 128(7): 1257.     CrossRef
• State-of-the-Art Clinical Microbiology in South Korea: Current Trends and Future Prospects
  Garima Sharma, Jin-Chul Kim
  Microorganisms.2022; 10(1): 174.     CrossRef
• Tea Polyphenols Prevent and Intervene in COVID-19 through Intestinal Microbiota
  Qiao Xiang, Lu Cheng, Ruilin Zhang, Yanan Liu, Zufang Wu, Xin Zhang
  Foods.2022; 11(4): 506.     CrossRef
• Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?
  Leon M. T. Dicks, Shelly M. Deane, Matthew J. Grobbelaar
  Probiotics and Antimicrobial Proteins.2022; 14(2): 217.     CrossRef
• A proposal for the reference intervals of the Italian microbiota “scaffold” in healthy adults
  Davide Sisti, Valerio Pazienza, Fabio Piccini, Barbara Citterio, Wally Baffone, Sabrina Donati Zeppa, Francesca Biavasco, Emilia Prospero, Antonio De Luca, Marco Artico, Samanta Taurone, Andrea Minelli, Francesco Perri, Elena Binda, Riccardo Pracella, Ric
  Scientific Reports.2022;[Epub]     CrossRef
• Gut microbiota in gastrointestinal diseases during pregnancy
  Zhong-Zhen Liu, Jing-Hua Sun, Wen-Jing Wang
  World Journal of Clinical Cases.2022; 10(10): 2976.     CrossRef
• Simulated elephant colon for cellulose extraction from sugarcane bagasse: An effective pretreatment to reduce chemical use
  Chotiwit Sriwong, Prakit Sukyai
  Science of The Total Environment.2022; 835: 155281.     CrossRef
• Does Lactobacillus reuteri influence ergothioneine levels in the human body?
  Irwin K. Cheah, Jovan Z. Lee, Richard M. Y. Tang, Pei Wen Koh, Barry Halliwell
  FEBS Letters.2022; 596(10): 1241.     CrossRef
• Insights into diet-associated oxidative pathomechanisms in inflammatory bowel disease and protective effects of functional amino acids
  Yun Ji, Ying Yang, Shiqiang Sun, Zhaolai Dai, Fazheng Ren, Zhenlong Wu
  Nutrition Reviews.2022; 81(1): 95.     CrossRef
• Untangling the oral–gut axis in the pathogenesis of intestinal inflammation
  Sho Kitamoto, Nobuhiko Kamada
  International Immunology.2022; 34(9): 485.     CrossRef
• Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials
  Chien-Tai Hong, Jia-Hung Chen, Tsai-Wei Huang
  Aging.2022; 14(17): 7014.     CrossRef
• Lactobacillus plantarum BSGP201683 Improves the Intestinal Barrier of Giant Panda Microbiota-Associated Mouse Infected by Enterotoxigenic Escherichia coli K88
  Yi Zhou, Xueqin Ni, Ling Duan, Lili Niu, Qian Liu, Yan Zeng, Qiang Wang, Jie Wang, Abdul Khalique, Kangcheng Pan, Bo Jing, Dong Zeng
  Probiotics and Antimicrobial Proteins.2021; 13(3): 664.     CrossRef
• Study on the additive protective effect of PGLYRP3 and Bifidobacterium adolescentis Reuter 1963 on severity of DSS-induced colitis in Pglyrp3 knockout (Pglyrp3 −/−) and wild-type (WT) mice
  Darab Ghadimi, Michael de Vrese, Michael Ebsen, Christoph Röcken, Sven Olaf Frahm, Janine Zahlten, Regina Fölster-Holst, Knut J. Heller, Wilhelm Bockelmann
  Immunobiology.2021; 226(1): 152028.     CrossRef
• Are silver nanoparticles better than triclosan as a daily antimicrobial? Answers from the perspectives of gut microbiome disruption and pathogenicity
  Mingzhu Li, Chengdong Zhang
  Science of The Total Environment.2021; 756: 143983.     CrossRef
• (Mögliche) Rolle des Mikrobioms in der Diagnostik, Therapie und Genese des Kolonkarzinoms
  Christian Schulz, Alexander Neuner, Christoph A. Jacobi
  Der Onkologe.2021; 27(3): 195.     CrossRef
• Giardia spp. and the Gut Microbiota: Dangerous Liaisons
  Elena Fekete, Thibault Allain, Affan Siddiq, Olivia Sosnowski, Andre G. Buret
  Frontiers in Microbiology.2021;[Epub]     CrossRef
• Astragalin Inhibits Nuclear Factor-κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice
  Yoo Min Han, Jaemoon Koh, Jee Hyun Kim, Jooyoung Lee, Jong Pil Im, Joo Sung Kim
  Gut and Liver.2021; 15(1): 100.     CrossRef
• Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs)
  Toumi Ryma, Arezki Samer, Imene Soufli, Hayet Rafa, Chafia Touil-Boukoffa
  Gastroenterology Insights.2021; 12(1): 56.     CrossRef
• Health risk assessment based on metal analysis of soil and crops in Al-Dakhla Oasis
  Hosam M. Saleh, Hazem H. Mahmoud, Mona I. Abdou, Samir B. Eskander
  Arabian Journal of Geosciences.2021;[Epub]     CrossRef
• Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer
  Yiming Yin, Mengge Wang, Wenjie Gu, Lili Chen
  Biochemical Pharmacology.2021; 186: 114430.     CrossRef
• The microbiota is dispensable for the early stages of peripheral regulatory T cell induction within mesenteric lymph nodes
  Carolin Wiechers, Mangge Zou, Eric Galvez, Michael Beckstette, Maria Ebel, Till Strowig, Jochen Huehn, Joern Pezoldt
  Cellular & Molecular Immunology.2021; 18(5): 1211.     CrossRef
• Gastroprotective Effects of Polyphenols against Various Gastro-Intestinal Disorders: A Mini-Review with Special Focus on Clinical Evidence
  Hui-Fang Chiu, Kamesh Venkatakrishnan, Oksana Golovinskaia, Chin-Kun Wang
  Molecules.2021; 26(7): 2090.     CrossRef
• Isolation and genomic characterization of five novel strains of Erysipelotrichaceae from commercial pigs
  Jinyuan Wu, Min Liu, Mengqing Zhou, Lin Wu, Hui Yang, Lusheng Huang, Congying Chen
  BMC Microbiology.2021;[Epub]     CrossRef
• Impact of the Gut Microbiota Balance on the Health–Disease Relationship: The Importance of Consuming Probiotics and Prebiotics
  Laura-Berenice Olvera-Rosales, Alma-Elizabeth Cruz-Guerrero, Esther Ramírez-Moreno, Aurora Quintero-Lira, Elizabeth Contreras-López, Judith Jaimez-Ordaz, Araceli Castañeda-Ovando, Javier Añorve-Morga, Zuli-Guadalupe Calderón-Ramos, José Arias-Rico, Luis-G
  Foods.2021; 10(6): 1261.     CrossRef
• Septic arthritis caused by Desulfovibrio desulfuricans: A case report and review of the literature
  Timothy J. Marquis, Vincent J. Williams, David B. Banach
  Anaerobe.2021; : 102407.     CrossRef
• Pathogenetic factors of ulcerative colitis: mainstream for 2020
  G. R. Bicbavova, M. A. Livzan, M. Yu. Lozinskaya
  Bulletin of Siberian Medicine.2021; 20(2): 130.     CrossRef
• Effect of gut microbiome on minor complications after a colonoscopy
  Jae Hyun Kim, Youn Jung Choi, Hye Jung Kwon, Kyoungwon Jung, Sung Eun Kim, Won Moon, Moo In Park, Seun Ja Park
  Intestinal Research.2021; 19(3): 341.     CrossRef
• Gut Microbiota Community Shift with Severity of Coronary Artery Disease
  Jia-Lu Hu, Zhi-Feng Yao, Min-Na Tang, Chun Tang, Xiao-Fan Zhao, Xi Su, Dan-Bo Lu, Qiu-Rong Li, Zhang-Sheng Wang, Yan Yan, Zeneng Wang
  Engineering.2021; 7(12): 1715.     CrossRef
• Additional Candida albicans administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by Lactobacillus rhamnosus L34
  Wimonrat Panpetch, Pratsanee Hiengrach, Sumanee Nilgate, Somying Tumwasorn, Naraporn Somboonna, Alisa Wilantho, Piraya Chatthanathon, Piyapan Prueksapanich, Asada Leelahavanichkul
  Gut Microbes.2020; 11(3): 465.     CrossRef
• The Regulation of Host Intestinal Microbiota by Polyphenols in the Development and Prevention of Chronic Kidney Disease
  Naren Bao, Fangjie Chen, Di Dai
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Adhesion and anti-inflammatory potential ofLactobacillus rhamnosusGG in a sea buckthorn based beverage matrix
  Srijita Sireswar, Sutapa Biswas, Gargi Dey
  Food & Function.2020; 11(3): 2555.     CrossRef
• Intestinal epithelial barrier and neuromuscular compartment in health and disease
  Vanessa D’Antongiovanni, Carolina Pellegrini, Matteo Fornai, Rocchina Colucci, Corrado Blandizzi, Luca Antonioli, Nunzia Bernardini
  World Journal of Gastroenterology.2020; 26(14): 1564.     CrossRef
• The impact of acute stress disorder on gallbladder interstitial cells of Cajal
  Zhen‐peng Huang, Hu Qiu, Ke Wang, Wei‐bo Chao, Hao‐bin Zhu, Hang Chen, Yue Liu, Bao‐ping Yu
  Journal of Cellular Physiology.2020; 235(11): 8424.     CrossRef
• The relationship between the commensal microbiota levels and Crohn's disease activity
  Hagamenon de Alencar Junior, Ana Paula Ribeiro Paiotti, Humberto Bezerra de Araújo Filho, Celina Tizuko Fujiyama Oshima, Sender Jankiel Miszputen, Orlando Ambrogini‐Júnior
  JGH Open.2020; 4(5): 784.     CrossRef
• Gut microbiota health closely associates with PCB153-derived risk of host diseases
  Lingli Min, Yulang Chi, Sijun Dong
  Ecotoxicology and Environmental Safety.2020; 203: 111041.     CrossRef
• Comparison of Gut Microbiota Diversity and Predicted Functions Between Healthy and Diseased Captive Rana dybowskii
  Qing Tong, Li-Yong Cui, Xiao-Peng Du, Zong-Fu Hu, Jia Bie, Jian-Hua Xiao, Hong-Bin Wang, Jian-Tao Zhang
  Frontiers in Microbiology.2020;[Epub]     CrossRef
• Intestinal microbiocenosis in patients with recurrent Clostridium difficile infection, ulcerative colitis and irritable bowel syndrome after transplantation of fecal microflora
  E. V. Shrainer, A. I. Khavkin, V. V. Vlasov
  Experimental and Clinical Gastroenterology.2020; (7): 69.     CrossRef
• Detection of Streptococcus gallolyticus in colorectal cancer and inflammatory bowel disease patients compared to control group in southwest of Iran
  Ahmad Farajzadeh Sheikh, Abdol Rahim Masjedi Zadeh, Morteza Saki, Parisa Khani, Seyed Jalal Hashemi, Sam Shahin Zadeh, Maryam Dastoorpoor
  Molecular Biology Reports.2020; 47(11): 8361.     CrossRef
• An analysis of gut dysbiosis in obesity, diabetes, and chronic gut conditions
  Ahmed Haleem, Sama Anvari, Aisha Nazli, Mohamed Sager, Mahmood Akhtar
  Ibnosina Journal of Medicine and Biomedical Sciences.2020; 12(04): 264.     CrossRef
• Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19
  Taha Baghbani, Hossein Nikzad, Javid Azadbakht, Fatemeh Izadpanah, Hamed Haddad Kashani
  Microbial Cell Factories.2020;[Epub]     CrossRef
• Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
  Marta Hernández, Mónica de Frutos, David Rodríguez-Lázaro, Luis López-Urrutia, Narciso M. Quijada, Jose María Eiros
  Frontiers in Microbiology.2019;[Epub]     CrossRef
• Hsp60 as a Novel Target in IBD Management: A Prospect
  Francesco Cappello, Margherita Mazzola, Abdo Jurjus, Marie-Noel Zeenny, Rosalyn Jurjus, Francesco Carini, Angelo Leone, Giuseppe Bonaventura, Giovanni Tomasello, Fabio Bucchieri, Everly Conway de Macario, Alberto J. L. Macario
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• Intestinibaculum porci gen. nov., sp. nov., a new member of the family Erysipelotrichaceae isolated from the small intestine of a swine
  Ji-Sun Kim, Hanna Choe, Yu-Ri Lee, Kyung Mo Kim, Doo-Sang Park
  Journal of Microbiology.2019; 57(5): 381.     CrossRef
• Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study
  Kookhwan Choi, Jaeyoung Chun, Kyungdo Han, Seona Park, Hosim Soh, Jihye Kim, Jooyoung Lee, Hyun Lee, Jong Im, Joo Kim
  Journal of Clinical Medicine.2019; 8(5): 654.     CrossRef
• Novel Selective Estrogen Receptor Modulator Ameliorates Murine Colitis
  Lauri Polari, Santeri Anttila, Terhi Helenius, Anu Wiklund, Tero Linnanen, Diana M. Toivola, Jorma Määttä
  International Journal of Molecular Sciences.2019; 20(12): 3007.     CrossRef
• Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes?
  Chiara Pellicano, Giorgia Leodori, Giuseppe Pietro Innocenti, Antonietta Gigante, Edoardo Rosato
  Nutrients.2019; 11(11): 2629.     CrossRef
• Impact of microbiota in colorectal carcinogenesis: lessons from experimental models
  Linda Chia-Hui Yu, Shu-Chen Wei, Yen-Hsuan Ni
  Intestinal Research.2018; 16(3): 346.     CrossRef
• Partial to complete abrogation of the subepithelial macrophage barrier against the gut microbiota in patients with ulcerative colitis and Crohn's colitis
  Carlos A Rubio, Cord Langner, Peter T Schmidt
  Histopathology.2018; 72(4): 580.     CrossRef
• Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer
  Veronica Lazar, Lia-Mara Ditu, Gratiela Gradisteanu Pircalabioru, Irina Gheorghe, Carmen Curutiu, Alina Maria Holban, Ariana Picu, Laura Petcu, Mariana Carmen Chifiriuc
  Frontiers in Immunology.2018;[Epub]     CrossRef
• How to improve the gluten-free diet: The state of the art from a food science perspective
  Marco Gobbetti, Erica Pontonio, Pasquale Filannino, Carlo Giuseppe Rizzello, Maria De Angelis, Raffaella Di Cagno
  Food Research International.2018; 110: 22.     CrossRef
• Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study]
  Magne Henriksen, Marte Lie Høivik, Lars-Petter Jelsness-Jørgensen, Bjørn Moum
  Journal of Crohn's and Colitis.2018; 12(4): 389.     CrossRef
• Trace Element and Heavy Metal Levels in Colorectal Cancer: Comparison Between Cancerous and Non-cancerous Tissues
  Masoudreza Sohrabi, Ali Gholami, MohammadHossein Hosseini Azar, Mohammad Yaghoobi, Maryamosadat Mirasgari Shahi, Solmaz Shirmardi, Mehdi Nikkhah, Zahra Kohi, Delaram Salehpour, Mahmood Reza Khoonsari, Gholamrez Hemmasi, Farhad Zamani, Mahmoudreza Sohrabi,
  Biological Trace Element Research.2018; 183(1): 1.     CrossRef
• Endoscopic Transplantation of Mesenchymal Stem Cell Sheets in Experimental Colitis in Rats
  Sehyung Pak, Sung Wook Hwang, In Kyong Shim, Sang Mun Bae, Yeon- Mi Ryu, Han-Byul Kim, Eun-ju Do, Hye-Nam Son, Eun-ji Choi, Sun-ha Park, Sang-Yeob Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Nobuo Kanai, Masanori Maeda, Teruo Okano, Dong-Hoon Yang
  Scientific Reports.2018;[Epub]     CrossRef
• Advances in Probiotic Regulation of Bone and Mineral Metabolism
  Laura R. McCabe, Narayanan Parameswaran
  Calcified Tissue International.2018; 102(4): 480.     CrossRef
• Shifts of Faecal Microbiota During Sporadic Colorectal Carcinogenesis
  Giorgia Mori, Simone Rampelli, Beatrice Silvia Orena, Claudia Rengucci, Giulia De Maio, Giulia Barbieri, Alessandro Passardi, Andrea Casadei Gardini, Giovanni Luca Frassineti, Stefano Gaiarsa, Alessandra M. Albertini, Guglielmina Nadia Ranzani, Daniele Ca
  Scientific Reports.2018;[Epub]     CrossRef
• An analysis of dietary fiber and fecal fiber components including pH in rural Africans with colorectal cancer
  Mohammed Faruk, Sani Ibrahim, Ahmed Adamu, Abdulmumini Hassan Rafindadi, Yahaya Ukwenya, Yawale Iliyasu, Abdullahi Adamu, Surajo Mohammed Aminu, Mohammed Sani Shehu, Danladi Amodu Ameh, Abdullahi Mohammed, Saad Aliyu Ahmed, John Idoko, Atara Ntekim, Aisha
  Intestinal Research.2018; 16(1): 99.     CrossRef
• Disparate effects of antibiotics on hypertension
  S. Galla, S. Chakraborty, X. Cheng, J. Yeo, B. Mell, H. Zhang, A. V. Mathew, M. Vijay-Kumar, B. Joe
  Physiological Genomics.2018; 50(10): 837.     CrossRef
• The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview
  Amosy E. M’Koma
  Gastrointestinal Disorders.2018; 1(1): 75.     CrossRef
• Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease
  Shinichiro Shinzaki, Toshimitsu Fujii, Shigeki Bamba, Maiko Ogawa, Taku Kobayashi, Masahide Oshita, Hiroki Tanaka, Keiji Ozeki, Sakuma Takahashi, Hiroki Kitamoto, Kazuhito Kani, Sohachi Nanjo, Takeshi Sugaya, Yuko Sakakibara, Toshihiro Inokuchi, Kazuki Ka
  Intestinal Research.2018; 16(4): 609.     CrossRef
• Microbiome, gut dysbiosis and inflammatory bowel disease: That moment when the function is more important than taxonomy
  S. I. Sitkin, T. Ya. Vakhitov, E. V. Demyanova
  Almanac of Clinical Medicine.2018; 46(5): 396.     CrossRef
• Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
  Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2018; 12(5): 544.     CrossRef
• Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
  Shinta Mizuno, Kosaku Nanki, Katsuyoshi Matsuoka, Keiichiro Saigusa, Keiko Ono, Mari Arai, Shinya Sugimoto, Hiroki Kiyohara, Moeko Nakashima, Kozue Takeshita, Makoto Naganuma, Wataru Suda, Masahira Hattori, Takanori Kanai
  Intestinal Research.2017; 15(1): 68.     CrossRef
• Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders
  Uday C. Ghoshal, Ujjala Ghoshal
  Gastroenterology Clinics of North America.2017; 46(1): 103.     CrossRef
• Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice
  Lien Van den Bossche, Pieter Hindryckx, Lindsey Devisscher, Sarah Devriese, Sophie Van Welden, Tom Holvoet, Ramiro Vilchez-Vargas, Marius Vital, Dietmar H. Pieper, Julie Vanden Bussche, Lynn Vanhaecke, Tom Van de Wiele, Martine De Vos, Debby Laukens, Chri
  Applied and Environmental Microbiology.2017;[Epub]     CrossRef
• Host-microbial Cross-talk in Inflammatory Bowel Disease
  Hiroko Nagao-Kitamoto, Nobuhiko Kamada
  Immune Network.2017; 17(1): 1.     CrossRef
• Emerging Topics in Gastroenterology
  Gretchen Irwin, Laura Mayans, Rick Kellerman
  Primary Care: Clinics in Office Practice.2017; 44(4): 733.     CrossRef
• Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion
  Ruggiero Francavilla, Maria De Angelis, Carlo Giuseppe Rizzello, Noemi Cavallo, Fabio Dal Bello, Marco Gobbetti, Johanna Björkroth
  Applied and Environmental Microbiology.2017;[Epub]     CrossRef
• Stress and sleep quality in doctors working on-call shifts are associated with functional gastrointestinal disorders
  Soo-Kyung Lim, Seung Jin Yoo, Dae Lim Koo, Chae A Park, Han Jun Ryu, Yong Jin Jung, Ji Bong Jeong, Byeong Gwan Kim, Kook Lae Lee, Seong-Joon Koh
  World Journal of Gastroenterology.2017; 23(18): 3330.     CrossRef
• Microbiotal-Host Interactions and Hypertension
  Sarah Galla, Saroj Chakraborty, Blair Mell, Matam Vijay-Kumar, Bina Joe
  Physiology.2017; 32(3): 224.     CrossRef
• Effect of gut microbiota on host whole metabolome
  Takeo Moriya, Yoshinori Satomi, Shumpei Murata, Hiroshi Sawada, Hiroyuki Kobayashi
  Metabolomics.2017;[Epub]     CrossRef
• The gastrointestinal microbiota and its role in oncogenesis
  S.Y. Lam, J. Yu, S.H. Wong, M.P. Peppelenbosch, G.M. Fuhler
  Best Practice & Research Clinical Gastroenterology.2017; 31(6): 607.     CrossRef
• Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
  Inés Mármol, Cristina Sánchez-de-Diego, Alberto Pradilla Dieste, Elena Cerrada, María Rodriguez Yoldi
  International Journal of Molecular Sciences.2017; 18(1): 197.     CrossRef
• Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
  Duk Hwan Kim, Jae Hee Cheon
  Immune Network.2017; 17(1): 25.     CrossRef
• Duodenal endoluminal barrier sleeve alters gut microbiota of ZDF rats
  T Kim, C L Holleman, T Ptacek, C D Morrow, K M Habegger
  International Journal of Obesity.2017; 41(3): 381.     CrossRef
• NF-kappa B activation correlates with disease phenotype in Crohn’s disease
  Yoo Min Han, Jaemoon Koh, Ji Won Kim, Changhyun Lee, Seong-Joon Koh, ByeongGwan Kim, Kook Lae Lee, Jong Pil Im, Joo Sung Kim, Gernot Sellge
  PLOS ONE.2017; 12(7): e0182071.     CrossRef
• Microbial approaches for targeting antibiotic‐resistant bacteria
  Wing Fei Wong, Marina Santiago
  Microbial Biotechnology.2017; 10(5): 1047.     CrossRef
• Dysbiosis a risk factor for celiac disease
  Anamaria Girbovan, Genel Sur, Gabriel Samasca, Iulia Lupan
  Medical Microbiology and Immunology.2017; 206(2): 83.     CrossRef
• Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota
  Michail Karavolos, Alina Holban
  Pharmaceuticals.2016; 9(4): 62.     CrossRef

Citations

Citations to this article as recorded by  

• A retrospective study of neonatal and pregnancy outcomes in pregnant women suffering from inflammatory arthropathy treated with adalimumab
  Navid Najarpour, Elham Rajaei, Karim Mowla, Alireza Ghanbaran
  Revista Colombiana de Reumatología.2024; 31(3): 290.     CrossRef
• Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review
  Wei Huang, Xinxing Zhang, Li Zhang, Xiaosong Dai, Heping Chen, Qin Xie
  BMC Pregnancy and Childbirth.2024;[Epub]     CrossRef
• A retrospective study of neonatal and pregnancy outcomes in pregnant women suffering from inflammatory arthropathy treated with adalimumab
  Navid Najarpour, Elham Rajaei, Karim Mowla, Alireza Ghanbaran
  Revista Colombiana de Reumatología (English Edition).2024; 31(3): 290.     CrossRef
• Ulcerative Colitis in Pregnancy: A Japanese Multicenter Cohort Study Focusing on Their Mutual Influence
  Yuichi Shimodate, Akiko Shiotani, Ken-ichi Tarumi, Hiroshi Matsumoto, Osamu Handa, Noriaki Tomioka, Naoyuki Nishimura, Kazuhiro Matsueda, Hirokazu Mouri, Motowo Mizuno
  Internal Medicine.2024;[Epub]     CrossRef
• North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations
  Raed Alhusayen, Serena Dienes, Megan Lam, Afsaneh Alavi, Ali Alikhan, Maria Aleshin, Emad Bahashwan, Steve Daveluy, Noah Goldfarb, Amit Garg, Wayne Gulliver, Tarannum Jaleel, Alexa B. Kimball, Mark G. Kirchhof, Joslyn Kirby, Joi Lenczowski, Hadar Lev-Tov,
  Journal of the American Academy of Dermatology.2024;[Epub]     CrossRef
• The treatment of inflammatory bowel disease with monoclonal antibodies in Asia
  Yu Chen, Guolin Zhang, Yuewen Yang, Shuangshuang Zhang, Haozheng Jiang, Kang Tian, Arenbaoligao, Dapeng Chen
  Biomedicine & Pharmacotherapy.2023; 157: 114081.     CrossRef
• Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy
  Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Baw
  Saudi Journal of Gastroenterology.2023;[Epub]     CrossRef
• Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis
  Ole Haagen Nielsen, John Mark Gubatan, Carsten Bogh Juhl, Sarah Elizabeth Streett, Cynthia Maxwell
  Clinical Gastroenterology and Hepatology.2022; 20(1): 74.     CrossRef
• British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
  Mark D Russell, Mrinalini Dey, Julia Flint, Philippa Davie, Alexander Allen, Amy Crossley, Margreta Frishman, Mary Gayed, Kenneth Hodson, Munther Khamashta, Louise Moore, Sonia Panchal, Madeleine Piper, Clare Reid, Katherine Saxby, Karen Schreiber, Naz Se
  Rheumatology.2022;[Epub]     CrossRef
• Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis
  Yang Zhang, Dandan Li, Heng Guo, Weina Wang, Xingang Li, Su Shen
  Current Pharmaceutical Design.2021; 27(19): 2317.     CrossRef
• Exposure to Infliximab During Pregnancy: Post-Marketing Experience
  Anja Geldhof, Jennifer Slater, Michael Clark, Urmila Chandran, Danielle Coppola
  Drug Safety.2020; 43(2): 147.     CrossRef
• The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
  Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
  The Korean Journal of Internal Medicine.2020; 35(1): 41.     CrossRef
• The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
  Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
  Journal of Rheumatic Diseases.2020; 27(1): 4.     CrossRef
• Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies
  Nicole W Tsao, Nevena Rebic, Larry D Lynd, Mary A De Vera
  Rheumatology.2020; 59(8): 1808.     CrossRef
• Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review
  N. Ghalandari, R. J. E. M. Dolhain, J. M. W. Hazes, E. P. van Puijenbroek, M. Kapur, H. J. M. J. Crijns
  Drugs.2020; 80(16): 1699.     CrossRef
• Pregnancy and Neuromyelitis Optica Spectrum Disorder – Reciprocal Effects and Practical Recommendations: A Systematic Review
  Rohan D'Souza, Danielle Wuebbolt, Katarina Andrejevic, Rizwana Ashraf, Vanessa Nguyen, Nusrat Zaffar, Dalia Rotstein, Ahraaz Wyne
  Frontiers in Neurology.2020;[Epub]     CrossRef
• Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation
  Ayumi Ito, Bunei Iizuka, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige
  Internal Medicine.2018; 57(2): 159.     CrossRef
• The use of biologics and small molecules in pregnant patients with rheumatic diseases
  Maria Gerosa, Lorenza Maria Argolini, Carolina Artusi, Cecilia Beatrice Chighizola
  Expert Review of Clinical Pharmacology.2018; 11(10): 987.     CrossRef
• Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
  Ji Min Lee, Yoon Jae Kim, Kang-Moon Lee, Hyuk Yoon, Bo-In Lee, Dae Bum Kim, Donghoon Kang
  Scandinavian Journal of Gastroenterology.2018; 53(10-11): 1280.     CrossRef
• Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis
  Begoña Gonzalez-Suarez, Shreyashee Sengupta, Alan C Moss
  World Journal of Gastroenterology.2017; 23(45): 8082.     CrossRef
• Maternal and fetal outcomes in pregnant Japanese women with inflammatory bowel disease: our experience with a series of 23 cases
  Naoki Minami, Minoru Matsuura, Yorimitsu Koshikawa, Satoshi Yamada, Yusuke Honzawa, Shuji Yamamoto, Hiroshi Nakase
  Intestinal Research.2017; 15(1): 90.     CrossRef
• Concerns in pregnancy and childbirth of women with inflammatory bowel disease
  Sung-Ae Jung
  Intestinal Research.2016; 14(2): 107.     CrossRef
• Common Adverse Effects of Anti-TNF Agents on Gestation
  Zacharias Fasoulakis, Panagiotis Antsaklis, Nikolaos Galanopoulos, Emmanuel Kontomanolis
  Obstetrics and Gynecology International.2016; 2016: 1.     CrossRef

Citations

Citations to this article as recorded by  

• (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review
  Thomas Theo Brehm, Maja Reimann, Niklas Köhler, Christoph Lange
  Clinical Microbiology and Infection.2024; 30(8): 989.     CrossRef
• Real-world effectiveness of ustekinumab in maintenance therapy for Crohn´s disease
  O.V. Knyazev, O.B. Schukina, A.V. Kagramanova, A.A. Lishchinskaya, I.A. Li, E.A. Sabelnikova, B.A. Nanaeva, M.Yu. Timanovskaya, T.A. Kosacheva, N.A. Fadeeva, K.A. Nikolskaya, E.Yu. Zhulina, N.V. Kamzarakova, A.I. Parfenov
  Dokazatel'naya gastroenterologiya.2023; 12(3): 29.     CrossRef
• Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial
  William J. Sandborn, Rory Rebuck, Yuhua Wang, Bin Zou, Omoniyi J. Adedokun, Christopher Gasink, Bruce E. Sands, Stephen B. Hanauer, Stephan Targan, Subrata Ghosh, Willem J.S. de Villiers, Jean-Frederic Colombel, Brian G. Feagan, John P. Lynch
  Clinical Gastroenterology and Hepatology.2022; 20(3): 578.     CrossRef
• Monitoring frequency of interferon gamma release assay for tuberculosis surveillance following infliximab therapy in patients with Crohn's disease
  Qin Yu Yang, Yi Juan Liu, Ye Xu, Lin Zhang, Cheng Dang Wang
  Journal of Digestive Diseases.2021; 22(8): 473.     CrossRef
• Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
  Jihye Kim, Jong Pil Im, Jae-Joon Yim, Chang Kyun Lee, Dong Il Park, Chang Soo Eun, Sung-Ae Jung, Jeong Eun Shin, Kang-Moon Lee, Jae Hee Cheon
  The Korean Journal of Gastroenterology.2020; 75(1): 29.     CrossRef
• Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Hosim Soh, Jaeyoung Chun, Kyungdo Han, Seona Park, Gukhwan Choi, Jihye Kim, Jooyoung Lee, Jong Pil Im, Joo Sung Kim
  Gut and Liver.2019; 13(3): 333.     CrossRef
• Discontinuation of Biological Treatments in Inflammatory Bowel Disease
  Shomron Ben-Horin, Ren Mao, Yun Qiu, Minhu Chen
  Journal of Clinical Gastroenterology.2018; 52(1): 6.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
  Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Intestinal Research.2018; 16(1): 17.     CrossRef
• Novel treatments for inflammatory bowel disease
  Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
  The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
• Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
  Seong Jae Yeo, Hyun Seok Lee, Byung Ik Jang, Eun Soo Kim, Seong Woo Jeon, Sung Kook Kim, Kyeong Ok Kim, Yoo Jin Lee, Hyun Jik Lee, Kyung Sik Park, Yun Jin Jung, Eun Young Kim, Chang Heon Yang
  Intestinal Research.2018; 16(3): 400.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 2: Management
  Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin‐Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Journal of Gastroenterology and Hepatology.2018; 33(1): 30.     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease
  Jieun Kang, Dae Hyun Jeong, Minkyu Han, Suk-Kyun Yang, Jeong-Sik Byeon, Byong Duk Ye, Sang Hyoung Park, Sung Wook Hwang, Tae Sun Shim, Kyung-Wook Jo
  Journal of Korean Medical Science.2018;[Epub]     CrossRef
• CD8 + CD28 + /CD8 + CD28 − T cell equilibrium can predict the active stage for patients with inflammatory bowel disease
  Shi-xue Dai, Hong-xiang Gu, Qian-yi Lin, Shao-zhuo Huang, Tiao-si Xing, Qing-fang Zhang, Gang Wu, Min-hua Chen, Wan-er Tan, Hong-jian Jian, Zhong-wen Zheng, Tao Zhong, Min-hai Zhang, Xing-fang Cheng, Peng Huang, Guang-jie Liao, Wei-hong Sha
  Clinics and Research in Hepatology and Gastroenterology.2017; 41(6): 693.     CrossRef

Citations

Citations to this article as recorded by  

• Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
  Sisi Zhou, Zeyu Huang, Wenjing Hou, Yiting Lin, Jing Yu
  Inflammation Research.2024; 73(2): 199.     CrossRef
• Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: systematic review and network meta-analysis
  Brigida Barberio, David J Gracie, Christopher J Black, Alexander C Ford
  Gut.2023; 72(2): 264.     CrossRef
• Seronegative spondyloarthropathy-associated inflammatory bowel disease
  Chrong-Reen Wang, Hung-Wen Tsai
  World Journal of Gastroenterology.2023; 29(3): 450.     CrossRef
• Early Change in Fecal Calprotectin Predicts One‐Year Outcome in Children Newly Diagnosed With Ulcerative Colitis
  Chenthan Krishnakumar, Ashwin N. Ananthakrishnan, Brendan M. Boyle, Anne M. Griffiths, Neal S. LeLeiko, David R. Mack, James F. Markowitz, Joel R. Rosh, Cary G. Sauer, Thomas D. Walters, Erin Bonkowski, Lee A. Denson, Jeffrey S. Hyams, Subra Kugathasan
  Journal of Pediatric Gastroenterology and Nutrition.2022; 74(1): 72.     CrossRef
• Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis
  Gerd R. Burmester, Kenneth B. Gordon, James T. Rosenbaum, Dilek Arikan, Winnie L. Lau, Peigang Li, Freddy Faccin, Remo Panaccione
  Advances in Therapy.2020; 37(1): 364.     CrossRef
• Comparative Evaluation of 4 Commercially Available ELISA Kits for Measuring Adalimumab and Anti-adalimumab Antibodies
  Melissa Joyce Sam, Susan Jane Connor, Watson Wa-Sang Ng, Catherine Mei-Ling Toong
  Therapeutic Drug Monitoring.2020; 42(6): 821.     CrossRef
• Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
  Seong Jae Yeo, Hyun Seok Lee, Byung Ik Jang, Eun Soo Kim, Seong Woo Jeon, Sung Kook Kim, Kyeong Ok Kim, Yoo Jin Lee, Hyun Jik Lee, Kyung Sik Park, Yun Jin Jung, Eun Young Kim, Chang Heon Yang
  Intestinal Research.2018; 16(3): 400.     CrossRef
• Updated treatment strategies for intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn’s Disease: A Hospital-Based Cohort Study from Korea
  Hyungil Seo, Byong Duk Ye, Eun Mi Song, Sun-Ho Lee, Kiju Chang, Ho-Su Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
  Digestive Diseases and Sciences.2017; 62(10): 2882.     CrossRef
• Rare occurrence of inflammatory bowel disease in a cohort of Han Chinese ankylosing spondylitis patients- a single institute study
  Chrong-Reen Wang, Chia-Tse Weng, Chung-Ta Lee, Kuo-Yuan Huang, Sheng-Min Hsu, Ming-Fei Liu
  Scientific Reports.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Endoscopic treatments for rectal neuroendocrine tumors: a systematic review and network meta-analysis
  Jie Chen, Jianfang Ye, Xiong Zheng, Jianyong Chen
  Journal of Gastrointestinal Surgery.2024; 28(3): 301.     CrossRef
• Endoscopic mucosal resection using anchored snare Tip-in versus precut technique for small rectal neuroendocrine tumors
  Seung Wook Hong, Dong-Hoon Yang, Yoo Jin Lee, Dong Hoon Baek, Jaeyoung Chun, Hyun Gun Kim, Sung Joo Kim, Seung-Mo Hong, Dae-Seong Myung
  The Korean Journal of Internal Medicine.2024; 39(2): 238.     CrossRef
• Outcome of Endoscopic Resection of Rectal Neuroendocrine Tumors ≤ 10 mm
  Roberta Elisa Rossi, Maria Terrin, Silvia Carrara, Roberta Maselli, Alexia Francesca Bertuzzi, Silvia Uccella, Andrea Gerardo Antonio Lania, Alessandro Zerbi, Cesare Hassan, Alessandro Repici
  Diagnostics.2024; 14(14): 1484.     CrossRef
• Clinical outcomes of endoscopic resection for rectal neuroendocrine tumors: Advantages of endoscopic submucosal resection with a ligation device compared to conventional EMR and ESD
  Yuki Kamigaichi, Ken Yamashita, Shiro Oka, Hirosato Tamari, Yasutsugu Shimohara, Tomoyuki Nishimura, Katsuaki Inagaki, Yuki Okamoto, Hidenori Tanaka, Ryo Yuge, Yuji Urabe, Koji Arihiro, Shinji Tanaka
  DEN Open.2022;[Epub]     CrossRef
• Endoscopic Mucosal Resection in Children
  David S. Vitale, Kelly Wang, Laith H. Jamil, Kenneth H. Park, Quin Y. Liu
  Journal of Pediatric Gastroenterology and Nutrition.2022; 74(1): 20.     CrossRef
• Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance
  Camilla Gallo, Roberta Elisa Rossi, Federica Cavalcoli, Federico Barbaro, Ivo Boškoski, Pietro Invernizzi, Sara Massironi
  World Journal of Gastroenterology.2022; 28(11): 1123.     CrossRef
• Comparison of underwater endoscopic mucosal resection and endoscopic submucosal dissection of rectal neuroendocrine tumors (with videos)
  Sung Sil Park, Kyung Su Han, Bun Kim, Byung Chang Kim, Chang Won Hong, Dae Kyung Sohn, Hee Jin Chang
  Gastrointestinal Endoscopy.2020; 91(5): 1164.     CrossRef
• Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors
  Ai Fujimoto, Motoki Sasaki, Osamu Goto, Tadateru Maehata, Yasutoshi Ochiai, Motohiko Kato, Atsushi Nakayama, Teppei Akimoto, Jyunko Kuramoto, Yuichiro Hayashi, Kaori Kameyama, Naohisa Yahagi
  Internal Medicine.2019; 58(6): 773.     CrossRef
• Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors
  Masahide Ebi, Shoko Nakagawa, Yoshiharu Yamaguchi, Yasuhiro Tamura, Shinya Izawa, Yasutaka Hijikata, Takaya Shimura, Yasushi Funaki, Naotaka Ogasawara, Makoto Sasaki, Takashi Joh, Kunio Kasugai
  International Journal of Colorectal Disease.2018; 33(12): 1703.     CrossRef
• Neuroendocrine neoplasms of rectum: A management update
  Emilio Bertani, Davide Ravizza, Massimo Milione, Sara Massironi, Chiara Maria Grana, Dario Zerini, Alessandra Nella Piccioli, Giuseppe Spinoglio, Nicola Fazio
  Cancer Treatment Reviews.2018; 66: 45.     CrossRef

Citations

Citations to this article as recorded by  

• Cold snare polypectomy for fundic gland polyps
  Chi‐Hung Chen, Jen‐Chieh Huang, Jeng‐Shiann Shin
  Advances in Digestive Medicine.2022; 9(1): 17.     CrossRef
• Clinical features of fundic gland polyps and their correlation with colorectal tumors
  Xue-Mei Yang, Hong Xu
  World Chinese Journal of Digestology.2020; 28(20): 1036.     CrossRef
• Parietalzellhypertrophie und Drüsenkörperzysten
  M. Venerito, A. Canbay, M. Vieth
  Der Gastroenterologe.2018; 13(2): 90.     CrossRef

Citations

Citations to this article as recorded by  

• What doesn’t kill biofilm, makes them stronger: critical methodological considerations for endoscope reprocessing
  R. Kanaujia, A. Sharma, M. Biswal, V. Singh
  Journal of Hospital Infection.2025; 156: 135.     CrossRef
• Synthesis, Characterization and Investigation of Antimicrobial Activity of Orthophtaldehyde Nanoflowers
  Gülten CAN SEZGİN, Nilay ILDİZ
  Middle Black Sea Journal of Health Science.2023; 9(2): 245.     CrossRef
• A Manufacturer and User Facility Device Experience Analysis of Upper Aerodigestive Endoscopy Contamination: Is Flexible Laryngoscopy Different?
  Roy Jiang, David A. Kasle, Faisal Alzahrani, Nikita Kohli, Michael Z. Lerner
  The Laryngoscope.2021; 131(3): 598.     CrossRef
• Electrochemical and Spectrometric Study of Reactivity of Orthophthalaldehyde with Hydroxylamine: Mechanistic Considerations
  Joël Donkeng‐Dazie, Jiří Urban, Jiří Ludvík
  ChemistrySelect.2021; 6(20): 4881.     CrossRef
• Reactivity of orthophthalaldehyde with aliphatic, alicyclic and aromatic primary diamines: Electrochemical study and mechanistic considerations
  Joël Donkeng Dazie, Alan Liška, Jiří Urban, Jiří Ludvík
  Journal of Electroanalytical Chemistry.2018; 821: 131.     CrossRef
• Efficacy of Peracetic Acid (EndoPA®) for Disinfection of Endoscopes
  Ji Min Lee, Kang-Moon Lee, Dae Bum Kim, Se Eun Go, Sungwoo Ko, Yoongoo Kang, Solim Hong
  The Korean Journal of Gastroenterology.2018; 71(6): 319.     CrossRef
• Planarity of substituted pyrrole and furan rings in (3R*, 1′S*, 3′R*)-3-(1′-tert-butylamino-1′H, 3′ H-benzo[c]furan-3′-yl)-2-tert-butyl-2,3-dihydro-1H-benzo[c]pyrrol-1-one
  Joel Donkeng Dazie, Alan Liška, Jiří Ludvík, Jan Fábry, Michal Dušek, Václav Eigner
  Zeitschrift für Kristallographie - Crystalline Materials.2017; 232(6): 441.     CrossRef

Tumor necrosis factor-α inhibitors are now considered as standard therapy for patients with severe inflammatory bowel disease who do not respond to corticosteroids, but they carry a definite risk of reactivation of tuberculosis. We present a case in which a patient with inflammatory bowel disease developed a de novo tuberculosis infection after the start of anti-tumor necrosis factor-α treatment despite showing negative results in tuberculosis screening. Although there are many case reports of pleural, lymph nodal and disseminated tuberculosis following infliximab therapy, we present the first case report of rectal tuberculosis following infliximab therapy.

Citations

Citations to this article as recorded by  

• Rectal tuberculosis: A systematic review
  Poras Chaudhary, Ashutosh Nagpal, Sam B. Padala, Mangarai Mukund, Lalit K. Bansal, Romesh Lal
  Indian Journal of Tuberculosis.2022; 69(3): 268.     CrossRef
• A case of paradoxical response during anti-tuberculosis treatment in a patient with ulcerative colitis
  Shuhei Hosomi, Naoko Sugita, Atsushi Kanamori, Masaki Ominami, Koji Otani, Noriko Kamata, Fumio Tanaka, Yasuaki Nagami, Koichi Taira, Yasuhiro Fujiwara
  Clinical Journal of Gastroenterology.2022; 15(3): 592.     CrossRef
• Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
  Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi
  Intestinal Research.2021; 19(4): 419.     CrossRef
• Risk of tuberculosis with anti-tumor necrosis factor-alpha therapy in patients with psoriasis and psoriatic arthritis in Indian population
  Soumajyoti Sarkar, Saumya Panda, Byungsoo Kim, SmritiK Raychaudhuri, Asutosh Ghosh, SibaP Raychaudhuri
  Indian Journal of Dermatology, Venereology and Leprology.2020; 86(1): 1.     CrossRef
• Tuberculosis rectal: presentación clínica infrecuente y diagnóstico diferencial con enfermedad de Crohn
  M. Gompertz, L. Carreño, L.C. Gil La Rotta
  Revista de Gastroenterología de México.2019; 84(4): 524.     CrossRef
• Bacteriologically Determined De Novo Tuberculosis during Tumor Necrosis Factor-α Inhibitor Therapy
  Gen Takahashi, Hiroyuki Kobayashi, Yasuyuki Saito, Sho Ohsawa, Kuniaki Suzuki, Shinichi Ishihara, Takeshi Hisada
  Internal Medicine.2019; 58(24): 3593.     CrossRef
• Rectal tuberculosis: An uncommon clinical presentation and differential diagnosis with Crohn's disease
  M. Gompertz, L. Carreño, L.C. Gil La Rotta
  Revista de Gastroenterología de México (English Edition).2019; 84(4): 524.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
  Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Intestinal Research.2018; 16(1): 4.     CrossRef
• Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk assessment
  Dong II Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin‐Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Journal of Gastroenterology and Hepatology.2018; 33(1): 20.     CrossRef

Acute cytomegalovirus (CMV) infection occurs commonly in immunocompromised and immunocompetent patients, but is usually asymptomatic in the latter. Vascular events associated with acute CMV infection have been described, but are rare. Hence, such events are rarely reported in the literature. We report a case of pulmonary embolism secondary to acute CMV colitis in an immunocompetent 78-year-old man. The patient presented with fever and diarrhea. Colonic ulcers were diagnosed based on colonoscopy findings, and CMV was the proven etiology on pathological examination. The patient subsequently experienced acute respiratory failure. Pulmonary embolism was diagnosed based on the chest radiography and computed tomography findings. A diagnosis of acute CMV colitis complicated by pulmonary embolism was made. The patient was successfully treated with intravenous administration of unfractionated heparin and intravenous ganciclovir.

Citations

Citations to this article as recorded by  

• Venous thromboembolism in infectious diseases
  Priyanka P. Nigade, Sagar S. Dhanagar, Vandana S. Nikam
  Comparative Clinical Pathology.2025;[Epub]     CrossRef
• Cytomegalovirus-Induced Pericarditis, Pulmonary Embolism, and Transaminitis in an Immunocompetent Patient
  Waiz Wasey, Navpreet Badesha, Maria Rossi, Caitlin Carter, Samantha Bibee
  Cureus.2021;[Epub]     CrossRef
• Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review
  Manuela Ceccarelli, Emmanuele Venanzi Rullo, Giuseppe Nunnari
  European Journal of Clinical Microbiology & Infectious Diseases.2018; 37(3): 381.     CrossRef
• Venous thromboembolism related to cytomegalovirus infection
  Amar H. Kelkar, Kavitha S. Jacob, Eman B. Yousif, John J. Farrell
  Medicine.2017; 96(51): e9336.     CrossRef

Micronutrient deficiencies in Crohn's disease (CD) patients are not uncommon and usually result in a combination of reduced dietary intake, disease-related malabsorption, and a catabolic state. Decreased serum thiamine levels are often reported in patients with CD. Wernicke's encephalopathy (WE) is a severe form of thiamine deficiency that can cause serious neurologic complications. Although WE is known to occur frequently in alcoholics, a number of non-alcoholic causes have also been reported. Here, we report two cases of non-alcoholic WE that developed in two severely malnourished CD patients who were supported by prolonged total parenteral nutrition without thiamine supplementation. These patients complained of sudden-onset ophthalmopathy, cerebellar dysfunction, and confusion. Magnetic resonance imaging allowed definitive diagnosis for WE despite poor sensitivity. The intravenous administration of thiamine alleviated the symptoms of WE dramatically. We emphasize the importance of thiamine supplementation for malnourished patients even if they are not alcoholics, especially in those with CD.

Citations

Citations to this article as recorded by  

• Hospital Outcomes in Medical Patients With Alcohol-Related and Non–Alcohol-Related Wernicke Encephalopathy
  Roshaani Rasiah, Claudia Gregoriano, Beat Mueller, Alexander Kutz, Philipp Schuetz
  Mayo Clinic Proceedings.2024; 99(5): 740.     CrossRef
• LLL 44 – Module 3: Micronutrients in Chronic disease
  Hanna-Liis Lepp, Karin Amrein, Oguzhan S. Dizdar, Michael P. Casaer, Kursat Gundogan, Angélique M.E. de Man, Serge Rezzi, Arthur R.H. van Zanten, Alan Shenkin, Mette M. Berger
  Clinical Nutrition ESPEN.2024; 62: 285.     CrossRef
• The use of parenteral nutrition in patients with inflammatory bowel disease: A detailed guide on the indications, risks, and benefits
  David Kohler, Hannah Freid, Jennifer Cholewka, Megan Miller, Stephanie L. Gold
  Nutrition in Clinical Practice.2024; 39(5): 1026.     CrossRef
• Novel XIAP mutation with early-onset Crohn’s disease complicated with acute heart failure: a case report
  Chendong Peng, Yuang Jiang, Xianhong Ou, Lei Liao, Chengying Yang, Qiao Zhou, Yan Wei, Lijia Chang, Xinrong Fan
  BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
• A COMBINATION REVIEW ON EFFECT OF CITRUS JUICE AND METRONIDAZOLE IN INFLAMMATORY BOWEL DISEASE
  Deeksha, Shalini Saini, Meenakshi Bhatt
  International Journal of Research -GRANTHAALAYAH.2023;[Epub]     CrossRef
• Wernicke's encephalopathy in Crohn's disease and ulcerative colitis
  Erik Oudman, Jan W. Wijnia, Misha J. Oey, Mirjam van Dam, Albert Postma
  Nutrition.2021; 86: 111182.     CrossRef
• Stability of high-dose thiamine in parenteral nutrition for treatment of patients with Wernicke's encephalopathy
  Maciej Stawny, Aleksandra Gostyńska, Rafał Olijarczyk, Anna Jelińska, Magdalena Ogrodowczyk
  Clinical Nutrition.2020; 39(9): 2929.     CrossRef
• A Case Report of Nonalcoholic Gayet-Wernicke Encephalopathy: Don’t Miss Thiamine
  Kompal Jain, Jasveer Singh, Anant Jain, Tanvi Khera
  A&A Practice.2020; 14(8): e01230.     CrossRef
• Vitamin D deficiency is associated with disease activity in patients with Crohn’s disease
  Kyoung Ho Ko, You Sun Kim, Bo Kyung Lee, Jong Hyun Choi, Yong Moon Woo, Jin Young Kim, Jeong Seop Moon
  Intestinal Research.2019; 17(1): 70.     CrossRef
• A Case of Iatrogenic Wernicke Encephalopathy Following Prolonged Total Parenteral Nutrition
  Mustafa ÇETİNER, Sibel Canbaz Kabay, Özgül Ocak, Selahattin Ayas
  Mustafa Kemal Üniversitesi Tıp Dergisi.2018; 9(34): 99.     CrossRef
• Metronidazole-induced encephalopathy in a patient with Crohn's disease
  Jihye Kim, Jaeyoung Chun, Jae Yong Park, Seung Wook Hong, Joo Young Lee, Jin Woo Kang, Seongjun Hwang, Sang-Bae Ko, Jong Pil Im, Joo Sung Kim
  Intestinal Research.2017; 15(1): 124.     CrossRef
• Vitamins and Minerals in Inflammatory Bowel Disease
  Fayez K. Ghishan, Pawel R. Kiela
  Gastroenterology Clinics of North America.2017; 46(4): 797.     CrossRef
• A case report: Non-alcoholic Wernicke encephalopathy associated with polyneuropathy
  Hudong Liang, Lan Wu, Ling-ling Liu, Jinming Han, Jie Zhu, Tao Jin
  Journal of International Medical Research.2017; 45(6): 1794.     CrossRef
• Micronutrient deficiencies in inflammatory bowel disease: trivial or crucial?
  Soon Man Yoon
  Intestinal Research.2016; 14(2): 109.     CrossRef